Group I metabotropic glutamate receptor signalling and its implication in neurological disease

CNS and Neurological Disorders - Drug Targets

Volumn 9, Issue 5, 2010, Pages 574-595

  Ribeiro, Fabiola M ^a   Paquet, Maryse ^a   Cregan, Sean P ^a   Ferguson, Stephen S G ^a  

^a ROBARTS RESEARCH INSTITUTE   (Canada)

Author keywords

Alzheimer's disease; Drug addiction; Epilepsy; Fragile X syndrome; Huntington's disease; Metabotropic glutamate receptors; MGluR1 5; Parkinson's disease; Proteins; Stroke

Indexed keywords

METABOTROPIC RECEPTOR 1;

ALZHEIMER DISEASE; ARTICLE; BRAIN DISEASE; CELLULAR DISTRIBUTION; DRUG DEPENDENCE; EPILEPSY; EXCITOTOXICITY; FRAGILE X SYNDROME; HUMAN; HUNTINGTON CHOREA; NEUROLOGIC DISEASE; NONHUMAN; PARKINSON DISEASE; PROTEIN INTERACTION; STROKE;

EID: 78649281822     PISSN: 18715273     EISSN: None     Source Type: Journal    
DOI: 10.2174/187152710793361612     Document Type: Article

References (363)

1. Ferraguti, F.; Crepaldi, L.; Nicoletti, F. Metabotropic glutamate 1 receptor: current concepts and perspectivesx. Pharmacol. Rev., 2008, 60(4), 536-581.
2. Nakanishi, S.; Masu, M. Molecular diversity and functions of glutamate receptors. Annu., Rev., Biophys. Biomol. Struct., 1994, 23, 319-348.
3. Olney, J.W. New mechanisms of excitatory transmitter neurotoxicity. J. Neural Transm. Suppl., 1994, 43, 47-51.
4. Dingledine, R.; Borges, K.; Bowie, D.; Traynelis, S.F. The glutamate receptor ion channels. Pharmacol. Rev., 1999, 51(1), 7-61.
5. Pin, J.P.; Galvez, T.; Prezeau, L. Evolution, structure, and activation mechanism of family 3/C G-protein-coupled receptors. Pharmacol. Ther., 2003, 98(3), 325-354.
6. Conn, P.J.; Pin, J.P. Pharmacology and functions of metabotropic glutamate receptors. Annu. Rev. Pharmacol. Toxicol., 1997, 37, 205-237.
7. Gerber, U.; Gee, C.E.; Benquet, P. Metabotropic glutamate receptors: intracellular signaling pathways. Curr, Opin. Pharmacol., 2007, 7(1), 56-61.
8. Pin, J.P.; Duvoisin, R. The metabotropic glutamate receptors: structure and functions. Neuropharmacology, 1995, 34(1), 1-26.
9. Dhami, G.K.; Ferguson, S.S. Regulation of metabotropic glutamate receptor signaling, desensitization and endocytosis. Pharmacol. Ther., 2006, 111(1), 260-271.
10. Ferraguti, F.; Shigemoto, R. Metabotropic glutamate receptors. Cell Tissue Res., 2006, 326(2), 483-504.
11. Wieronska, J.M.; Pilc, A. Metabotropic glutamate receptors in the tripartite synapse as a target for new psychotropic drugs. Neurochem. Int., 2009, 55(1-3), 85-97
12. Schoepp, D.D. Unveiling the functions of presynaptic metabotropic glutamate receptors in the central nervous system. J. Pharmacol. Exp. Ther., 2001, 299(1), 12-20
13. Shigemoto, R.; Nomura, S.; Ohishi, H.; Sugihara, H.; Nakanishi, S.; Mizuno, N. Immunohistochemical localization of a metabotropic glutamate receptor, mGluR5, in the rat brain. Neurosci. Lett., 1993, 163(1), 53-57
14. Shigemoto, R.; Kinoshita, A.; Wada, E.; Nomura, S.; Ohishi, H.; Takada, M.; Flor, P.J.; Neki, A.; Abe, T.; Nakanishi, S.; Mizuno, N. Differential presynaptic localization of metabotropic glutamate receptor subtypes in the rat hippocampus. J. Neurosci., 1997, 17(19), 7503-7522
15. Baude, A.; Nusser, Z.; Roberts, J.D.; Mulvihill, E.; McIlhinney, R.A.; Somogyi, P. The metabotropic glutamate receptor (mGluR1 alpha) is concentrated at perisynaptic membrane of neuronal subpopulations as detected by immunogold reaction. Neuron, 1993, 11(4), 771-787
16. Park, Y.K.; Galik, J.; Ryu, P.D.; Randic, M. Activation of presynaptic group I metabotropic glutamate receptors enhances glutamate release in the rat spinal cord substantia gelatinosa. Neurosci. Lett., 2004, 361(1-3), 220-224
17. Paquet, M.; Smith, Y. Group I metabotropic glutamate receptors in the monkey striatum: subsynaptic association with glutamatergic and dopaminergic afferents. J. Neurosci., 2003, 23(20), 7659-7669
18. Cabello, N.; Gandia, J.; Bertarelli, D.C.; Watanabe, M.; Lluis, C.; Franco, R.; Ferre, S.; Lujan, R.; Ciruela, F. Metabotropic glutamate type 5, dopamine D2 and adenosine A2a receptors form higher order oligomers in living cells. J. Neurochem., 2009, 109(5), 1497-1507
19. Condorelli, D.F.; Dell'albani, P.; Corsaro, M.; Giuffrida, R.; Caruso, A.; Trovato, S.A.; Spinella, F.; Nicoletti, F.; Albanese, V.; Giuffrida Stella, A.M. Metabotropic glutamate receptor expression in cultured rat astrocytes and human gliomas. Neurochem. Res., 1997, 22(9), 1127-1133
20. Biber, K.; Laurie, D.J.; Berthele, A.; Sommer, B.; Tolle, T.R.; Gebicke-Harter, P.J.; van, C.D.; Boddeke, H.W. Expression and signaling of group I metabotropic glutamate receptors in astrocytes and microglia. J. Neurochem., 1999, 72(4), 1671-1680
21. Schools, G.P.; Kimelberg, H.K. mGluR3 and mGluR5 are the predominant metabotropic glutamate receptor mRNAs expressed in hippocampal astrocytes acutely isolated from young rats. J. Neurosci. Res., 1999, 58(4), 533-543
22. Cai, Z.; Schools, G.P.; Kimelberg, H.K. Metabotropic glutamate receptors in acutely isolated hippocampal astrocytes: developmental changes of mGluR5 mRNA and functional expression. Glia, 2000, 29(1), 70-80
23. Silva, G.A.; Theriault, E.; Mills, L.R.; Pennefather, P.S.; Feeney, C.J. Group I and II metabotropic glutamate receptor expression in cultured rat spinal cord astrocytes. Neurosci. Lett., 1999, 263(2-3), 117-120
24. Aronica, E.; van Vliet, E.A.; Mayboroda, O.A.; Troost, D.; da Silva, F.H.; Gorter, J.A. Upregulation of metabotropic glutamate receptor subtype mGluR3 and mGluR5 in reactive astrocytes in a rat model of mesial temporal lobe epilepsy. Eur. J. Neurosci., 2000, 12(7), 2333-2344
25. Ulas, J.; Satou, T.; Ivins, K.J.; Kesslak, J.P.; Cotman, C.W.; Balazs, R. Expression of metabotropic glutamate receptor 5 is increased in astrocytes after kainate-induced epileptic seizures. Glia, 2000, 30(4), 352-361
26. Aronica, E.; Gorter, J.A.; Jansen, G.H.; van Veelen, C.W.; van Rijen, P.C.; Ramkema, M.; Troost, D. Expression and cell distribution of group I and group II metabotropic glutamate receptor subtypes in taylor-type focal cortical dysplasia. Epilepsia, 2003, 44(6), 785-795
27. Ferraguti, F.; Corti, C.; Valerio, E.; Mion, S.; Xuereb, J. Activated astrocytes in areas of kainate-induced neuronal injury upregulate the expression of the metabotropic glutamate receptors 2/3 and 5. Exp. Brain Res., 2001, 137(1), 1-11
28. Neto, F.L.; Schadrack, J.; Platzer, S.; Zieglgansberger, W.; Tolle, T.R.; Castro-Lopes, J.M. Up-regulation of metabotropic glutamate receptor 3 mRNA expression in the cerebral cortex of monoarthritic rats. J. Neurosci. Res., 2001, 63(4), 356-367
29. Dolan, S.; Kelly, J.G.; Monteiro, A.M.; Nolan, A.M. Up-regulation of metabotropic glutamate receptor subtypes 3 and 5 in spinal cord in a clinical model of persistent inflammation and hyperalgesia. Pain, 2003, 106(3), 501-512
30. Aronica, E.; Catania, M.V.; Geurts, J.; Yankaya, B.; Troost, D. Immunohistochemical localization of group I and II metabotropic glutamate receptors in control and amyotrophic lateral sclerosis human spinal cord: upregulation in reactive astrocytes. Neuroscience, 2001, 105(2), 509-520
31. Anneser, J.M.; Chahli, C.; Ince, P.G.; Borasio, G.D.; Shaw, P.J. Glial proliferation and metabotropic glutamate receptor expression in amyotrophic lateral sclerosis. J. Neuropathol. Exp. Neurol., 2004, 63(8), 831-840
32. Geurts, J.J.; Wolswijk, G.; Bo, L.; van, d. V; Polman, C.H.; Troost, D.; Aronica, E. Altered expression patterns of group I and II metabotropic glutamate receptors in multiple sclerosis. Brain, 2003, 126(Pt 8), 1755-1766
33. Kew, J.N.; Kemp, J.A. Ionotropic and metabotropic glutamate receptor structure and pharmacology. Psychopharmacology (Berl.), 2005, 179(1), 4-29
34. Takahashi, K.; Tsuchida, K.; Tanabe, Y.; Masu, M.; Nakanishi, S. Role of the large extracellular domain of metabotropic glutamate receptors in agonist selectivity determination 1. J. Biol. Chem., 1993, 268(26), 19341-19345
35. Ritzen, A.; Mathiesen, J.M.; Thomsen, C. Molecular pharmacology and therapeutic prospects of metabotropic glutamate receptor allosteric modulators. Basic Clin. Pharmacol. Toxicol., 2005, 97(4), 202-213
36. Bear, M.F.; Huber, K.M.; Warren, S.T. The mGluR theory of fragile X mental retardation. Trends Neurosci., 2004, 27(7), 370-377
37. Kew, J.N. Positive and negative allosteric modulation of metabotropic glutamate receptors: emerging therapeutic potential. Pharmacol. Ther., 2004, 104(3), 233-244
38. Shipe, W.D.; Wolkenberg, S.E.; Williams, D.L., Jr.; Lindsley, C.W. Recent advances in positive allosteric modulators of metabotropic glutamate receptors. Curr. Opin. Drug Discov. Devel., 2005, 8(4), 449-457
39. Brauner-Osborne, H.; Krogsgaard-Larsen, P. Pharmacology of (S)-homoquisqualic acid and (S)-2-amino-5-phosphonopentanoic acid [(S)-AP5] at cloned metabotropic glutamate receptors. Br. J. Pharmacol., 1998, 123(2), 269-274
40. Schoepp, D.D.; Goldsworthy, J.; Johnson, B.G.; Salhoff, C.R.; Baker, S.R. 3,5-dihydroxyphenylglycine is a highly selective agonist for phosphoinositide-linked metabotropic glutamate receptors in the rat hippocampus. J. Neurochem., 1994, 63(2), 769-772
41. Doherty, A.J.; Palmer, M.J.; Henley, J.M.; Collingridge, G.L.; Jane, D.E. (RS)-2-chloro-5-hydroxyphenylglycine (CHPG) activates mGlu5, but no mGlu1, receptors expressed in CHO cells and potentiates NMDA responses in the hippocampus. Neuropharmacology, 1997, 36(2), 265-267
42. Clark, B.P.; Baker, S.R.; Goldsworthy, J.; Harris, J.R.; Kingston, A.E. (+)-2-Methyl-4-carboxyphenylglycine (LY367385) selectively antagonises metabotropic glutamate mGluR1 receptors. Bioorg. Med. Chem. Lett., 1997, 7(21), 2777-2780
43. Carroll, F.Y.; Stolle, A.; Beart, P.M.; Voerste, A.; Brabet, I.; Mauler, F.; Joly, C.; Antonicek, H.; Bockaert, J.; Muller, T.; Pin, J.P.; Prezeau, L. BAY36-7620: a potent non-competitive mGlu1 receptor antagonist with inverse agonist activity. Mol. Pharmacol., 2001, 59(5), 965-973
44. Gasparini, F.; Lingenhohl, K.; Stoehr, N.; Flor, P.J.; Heinrich, M.; Vranesic, I.; Biollaz, M.; Allgeier, H.; Heckendorn, R.; Urwyler, S.; Varney, M.A.; Johnson, E.C.; Hess, S.D.; Rao, S.P.; Sacaan, A.I.; Santori, E.M.; Velicelebi, G.; Kuhn, R. 2-Methyl-6-(phenylethynyl)-pyridine (MPEP), a potent, selective and systemically active mGlu5 receptor antagonist. Neuropharmacology, 1999, 38(10), 1493-1503
45. Cosford, N.D.; Tehrani, L.; Roppe, J.; Schweiger, E.; Smith, N.D.; Anderson, J.; Bristow, L.; Brodkin, J.; Jiang, X.; McDonald, I.; Rao, S.; Washburn, M.; Varney, M.A. 3-[(2-Methyl-1,3-thiazol-4-yl)ethynyl]-pyridine: a potent and highly selective metabotropic glutamate subtype 5 receptor antagonist with anxiolytic activity. J. Med. Chem., 2003, 46(2), 204-206
46. Knoflach, F.; Mutel, V.; Jolidon, S.; Kew, J.N.; Malherbe, P.; Vieira, E.; Wichmann, J.; Kemp, J.A. Positive allosteric modulators of metabotropic glutamate 1 receptor: characterization, mechanism of action, and binding site. Proc. Natl. Acad. Sci. USA, 2001, 98(23), 13402-13407
47. Wichmann, J.; Bleicher, K.; Vieira, E.; Woltering, T.; Knoflach, F.; Mutel, V. Alkyl diphenylacetyl, 9H-xanthene-and 9H-thioxanthene-carbonyl carbamates as positive allosteric modulators of mGlu1 receptors. Farmaco 2002, 57(12), 989-992
48. O'Brien, J.A.; Lemaire, W.; Chen, T.B.; Chang, R.S.; Jacobson, M.A.; Ha, S.N.; Lindsley, C.W.; Schaffhauser, H.J.; Sur, C.; Pettibone, D.J.; Conn, P.J.; Williams, D.L. Jr. A family of highly selective allosteric modulators of the metabotropic glutamate receptor subtype 5. Mol. Pharmacol., 2003, 64(3), 731-740
49. O'Brien, J.A.; Lemaire, W.; Wittmann, M.; Jacobson, M.A.; Ha, S.N.; Wisnoski, D.D.; Lindsley, C.W.; Schaffhauser, H.J.; Rowe, B.; Sur, C.; Duggan, M.E.; Pettibone, D.J.; Conn, P.J.; Williams, D.L. Jr. A novel selective allosteric modulator potentiates the activity of native metabotropic glutamate receptor subtype 5 in rat forebrain. J. Pharmacol. Exp. Ther., 2004, 309(2), 568-577
50. Lindsley, C.W.; Wisnoski, D.D.; Leister, W.H.; O'Brien, J.A.; Lemaire, W.; Williams, D.L. Jr.; Burno, M.; Sur, C.; Kinney, G.G.; Pettibone, D.J.; Tiller, P.R.; Smith, S.; Duggan, M.E.; Hartman, G.D.; Conn, P.J.; Huff, J.R. Discovery of positive allosteric modulators for the metabotropic glutamate receptor subtype 5 from a series of N-(1,3-diphenyl-1H-pyrazol-5-yl)benzamides that potentiate receptor function in vivo. J. Med. Chem., 2004, 47(24), 5825-5828
51. de, P.T.; Hemstapat, K.; Chen, Y.; Zhang, Y.; Saleh, S.; Alagille, D.; Baldwin, R.M.; Tamagnan, G.D.; Conn, P.J. Substituent effects of N-(1,3-diphenyl-1H-pyrazol-5-yl)benzamides on positive allosteric modulation of the metabotropic glutamate-5 receptor in rat cortical astrocytes. J. Med. Chem., 2006, 49(11), 3332-3344
52. Schlumberger, C.; Pietraszek, M.; Gravius, A.; Klein, K.U.; Greco, S.; More, L.; Danysz, W. Comparison of the mGlu(5) receptor positive allosteric modulator ADX47273 and the mGlu(2/3) receptor agonist LY354740 in tests for antipsychotic-like activity. Eur. J. Pharmacol., 2009, 623(1-3), 73-83
53. Malherbe, P.; Kew, J.N.; Richards, J.G.; Knoflach, F.; Kratzeisen, C.; Zenner, M.T.; Faull, R.L.; Kemp, J.A.; Mutel, V. Identification and characterization of a novel splice variant of the metabotropic glutamate receptor 5 gene in human hippocampus and cerebellum. Brain Res. Mol. Brain Res., 2002, 109(1-2), 168-178
54. Hirbec, H.; Perestenko, O.; Nishimune, A.; Meyer, G.; Nakanishi, S.; Henley, J.M.; Dev, K.K. The PDZ proteins PICK1, GRIP, and syntenin bind multiple glutamate receptor subtypes.Analysis of PDZ binding motifs. J. Biol. Chem., 2002, 277(18), 15221-15224
55. Enz, R. The trick of the tail: protein-protein interactions of metabotropic glutamate receptors. Bioessays, 2007, 29(1), 60-73
56. Ferraguti, F.; Conquet, F.; Corti, C.; Grandes, P.; Kuhn, R.; Knopfel, T. Immunohistochemical localization of the mGluR1beta metabotropic glutamate receptor in the adult rodent forebrain: evidence for a differential distribution of mGluR1 splice variants. J. Comp. Neurol., 1998, 400(3), 391-407
57. Alvarez, F.J.; Fyffe, R.E.; Dewey, D.E.; Haftel, V.K.; Cope, T.C. Factors regulating AMPA-type glutamate receptor subunit changes induced by sciatic nerve injury in rats. J. Comp. Neurol., 2000, 426(2), 229-242
58. Mateos, J.M.; Benitez, R.; Elezgarai, I.; Azkue, J.J.; Lazaro, E.; Osorio, A.; Bilbao, A.; Donate, F.; Sarria, R.; Conquet, F.; Ferraguti, F.; Kuhn, R.; Knopfel, T.; Grandes, P.Immunolocalization of the mGluR1b splice variant of the metabotropic glutamate receptor 1 at parallel fiber-Purkinje cell synapses in the rat cerebellar cortex. J. Neurochem., 2000, 74(3), 1301-1309
59. Hubert, G.W.; Paquet, M.; Smith, Y. Differential subcellular localization of mGluR1a and mGluR5 in the rat and monkey Substantia nigra. J. Neurosci., 2001, 21(6), 1838-1847
60. Kitano, J.; Kimura, K.; Yamazaki, Y.; Soda, T.; Shigemoto, R.; Nakajima, Y.; Nakanishi, S. Tamalin, a PDZ domain-containing protein, links a protein complex formation of group 1 metabotropic glutamate receptors and the guanine nucleotide exchange factor cytohesins 1. J. Neurosci., 2002, 22(4), 1280-1289
61. Tu, J.C.; Xiao, B.; Naisbitt, S.; Yuan, J.P.; Petralia, R.S.; Brakeman, P.; Doan, A.; Aakalu, V.K.; Lanahan, A.A.; Sheng, M.; Worley, P.F. Coupling of mGluR/Homer and PSD-95 complexes by the Shank family of postsynaptic density proteins. Neuron, 1999, 23(3), 583-592
62. Sugi, T.; Oyama, T.; Muto, T.; Nakanishi, S.; Morikawa, K.; Jingami, H. Crystal structures of autoinhibitory PDZ domain of Tamalin: implications for metabotropic glutamate receptor trafficking regulation. EMBO J., 2007, 26(8), 2192-2205
63. Tu, J.C.; Xiao, B.; Yuan, J.P.; Lanahan, A.A.; Leoffert, K.; Li, M.; Linden, D.J.; Worley, P.F. Homer binds a novel proline-rich motif and links group 1 metabotropic glutamate receptors with IP3 receptors. Neuron, 1998, 21(4), 717-726
64. Xiao, B.; Tu, J.C.; Petralia, R.S.; Yuan, J.P.; Doan, A.; Breder, C.D.; Ruggiero, A.; Lanahan, A.A.; Wenthold, R.J.; Worley, P.F. Homer regulates the association of group 1 metabotropic glutamate receptors with multivalent complexes of homer-related, synaptic proteins. Neuron, 1998, 21(4), 707-716
65. Soloviev, M.M.; Ciruela, F.; Chan, W.Y.; McIlhinney, R.A. Molecular characterisation of two structurally distinct groups of human homers, generated by extensive alternative splicing. J. Mol. Biol., 2000, 295(5), 1185-1200
66. Shiraishi, Y.; Mizutani, A.; Yuasa, S.; Mikoshiba, K.; Furuichi, T. Differential expression of Homer family proteins in the developing mouse brain. J. Comp. Neurol., 2004, 473(4), 582-599
67. Ango, F.; Pin, J.P.; Tu, J.C.; Xiao, B.; Worley, P.F.; Bockaert, J.; Fagni, L. Dendritic and axonal targeting of type 5 metabotropic glutamate receptor is regulated by homer1 proteins and neuronal excitation. J. Neurosci., 2000, 20(23), 8710-8716
68. Ango, F.; Robbe, D.; Tu, J.C.; Xiao, B.; Worley, P.F.; Pin, J.P.; Bockaert, J.; Fagni, L. Homer-dependent cell surface expression of metabotropic glutamate receptor type 5 in neurons. Mol. Cell Neurosci., 2002, 20(2), 323-329
69. Kammermeier, P.J. Surface clustering of metabotropic glutamate receptor 1 induced by long Homer proteins. BMC Neurosci., 2006, 7, 1
70. Ango, F.; Prezeau, L.; Muller, T.; Tu, J.C.; Xiao, B.; Worley, P.F.; Pin, J.P.; Bockaert, J.; Fagni, L. Agonist-independent activation of metabotropic glutamate receptors by the intracellular protein Homer. Nature, 2001, 411(6840), 962-965
71. Francesconi, A.; Kumari, R.; Zukin, R.S. Proteomic analysis reveals novel binding partners of metabotropic glutamate receptor 1. J. Neurochem., 2009, 108(6), 1515-1525
72. bdul-Ghani, M.A.; Valiante, T.A.; Carlen, P.L.; Pennefather, P.S. Metabotropic glutamate receptors coupled to IP3 production mediate inhibition of IAHP in rat dentate granule neurons. J. Neurophysiol., 1996, 76(4), 2691-2700
73. Paquet, M.; Asay, M.J.; Fam, S.R.; Inuzuka, H.; Castleberry, A.M.; Oller, H.; Smith, Y.; Yun, C.C.; Traynelis, S.F.; Hall, R.A. The PDZ scaffold NHERF-2 interacts with mGluR5 and regulates receptor activity. J. Biol. Chem., 2006, 281(40), 29949-29961
74. Hermans, E.; Challiss, R.A. Structural, signalling and regulatory properties of the group I metabotropic glutamate receptors: prototypic family C G-protein-coupled receptors. Biochem. J., 2001, 359(Pt 3), 465-484
75. Aramori, I.; Nakanishi, S. Signal transduction and pharmacological characteristics of a metabotropic glutamate receptor, mGluR1, in transfected CHO cells. Neuron, 1992, 8(4), 757-765
76. Francesconi, A.; Duvoisin, R.M. Opposing effects of protein kinase C and protein kinase A on metabotropic glutamate receptor signaling: selective desensitization of the inositol trisphosphate/Ca2+ pathway by phosphorylation of the receptor-G protein-coupling domain. Proc. Natl. Acad. Sci. USA, 2000, 97(11), 6185-6190
77. Thomsen, C. Metabotropic glutamate receptor subtype 1A activates adenylate cyclase when expressed in baby hamster kidney cells. Prog. Neuropsychopharmacol. Biol. Psychiatry, 1996, 20(4), 709-726
78. Francesconi, A.; Duvoisin, R.M. Role of the second and third intracellular loops of metabotropic glutamate receptors in mediating dual signal transduction activation. J. Biol. Chem., 1998, 273(10), 5615-5624
79. Parmentier, M.L.; Joly, C.; Restituito, S.; Bockaert, J.; Grau, Y.; Pin, J.P. The G protein-coupling profile of metabotropic glutamate receptors, as determined with exogenous G proteins, is independent of their ligand recognition domain. Mol. Pharmacol., 1998, 53(4), 778-786
80. Joly, C.; Gomeza, J.; Brabet, I.; Curry, K.; Bockaert, J.; Pin, J.P. Molecular, functional, and pharmacological characterization of the metabotropic glutamate receptor type 5 splice variants: comparison with mGluR1. J. Neurosci., 1995, 15(5 Pt 2), 3970-3981
81. Abe, T.; Sugihara, H.; Nawa, H.; Shigemoto, R.; Mizuno, N.; Nakanishi, S. Molecular characterization of a novel metabotropic glutamate receptor mGluR5 coupled to inositol phosphate/Ca2+ signal transduction. J. Biol. Chem., 1992, 267(19), 13361-13368
82. Balazs, R.; Miller, S.; Romano, C.; de, V.A.; Chun, Y.; Cotman, C.W. Metabotropic glutamate receptor mGluR5 in astrocytes: pharmacological properties and agonist regulation. J. Neurochem., 1997, 69(1), 151-163
83. Hiltscher, R.; Seuwen, K.; Boddeke, H.W.; Sommer, B.; Laurie, D.J. Functional coupling of human metabotropic glutamate receptor hmGlu1d: comparison to splice variants hmGlu1a and -1b. Neuropharmacology, 1998, 37(7), 827-837
84. Mary, S.; Stephan, D.; Gomeza, J.; Bockaert, J.; Pruss, R.M.; Pin, J.P. The rat mGlu1d receptor splice variant shares functional properties with the other short isoforms of mGlu1 receptor. Eur. J. Pharmacol., 1997, 335 (1), 65-72
85. Hermans, E.; Saunders, R.; Selkirk, J.V.; Mistry, R.; Nahorski, S.R.; Challiss, R.A. Complex involvement of pertussis toxin-sensitive G proteins in the regulation of type 1alpha metabotropic glutamate receptor signaling in baby hamster kidney cells. Mol. Pharmacol., 2000, 58(2), 352-360
86. Selkirk, J.V.; Price, G.W.; Nahorski, S.R.; Challiss, R.A. Cell type-specific differences in the coupling of recombinant mGlu1alpha receptors to endogenous G protein sub-populations. Neuropharmacology, 2001, 40(5), 645-656
87. Lester, R.A.; Jahr, C.E. Quisqualate receptor-mediated depression of calcium currents in hippocampal neurons. Neuron, 1990, 4(5), 741-749
88. Swartz, K.J.; Bean, B.P. Inhibition of calcium channels in rat CA3 pyramidal neurons by a metabotropic glutamate receptor. J. Neurosci., 1992, 12(11), 4358-4371
89. McCool, B.A.; Pin, J.P.; Harpold, M.M.; Brust, P.F.; Stauderman, K.A.; Lovinger, D.M. Rat group I metabotropic glutamate receptors inhibit neuronal Ca2+ channels via multiple signal transduction pathways in HEK 293 cells. J. Neurophysiol., 1998, 79(1), 379-391
90. Chavis, P.; Fagni, L.; Lansman, J.B.; Bockaert, J. Functional coupling between ryanodine receptors and L-type calcium channels in neurons. Nature, 1996, 382(6593), 719-722
91. Fagni, L.; Chavis, P.; Ango, F.; Bockaert, J. Complex interactions between mGluRs, intracellular Ca2+ stores and ion channels in neurons. Trends Neurosci., 2000, 23(2), 80-88
92. Kitano, J.; Yamazaki, Y.; Kimura, K.; Masukado, T.; Nakajima, Y.; Nakanishi, S. Tamalin is a scaffold protein that interacts with multiple neuronal proteins in distinct modes of protein-protein association. J. Biol. Chem., 2003, 278(17), 14762-14768
93. Fagni, L.; Bossu, J.L.; Bockaert, J. Activation of a large-conductance Ca2+-dependent K+ channel by stimulation of glutamate phosphoinositide-coupled receptors in cultured cerebellar granule cells. Eur. J. Neurosci., 1991, 3(8), 778-789
94. Sharon, D.; Vorobiov, D.; Dascal, N. Positive and negative coupling of the metabotropic glutamate receptors to a G protein-activated K+ channel, GIRK, in Xenopus oocytes. J. Gen. Physiol., 1997, 109(4), 477-490
95. Lu, W.Y.; Xiong, Z.G.; Lei, S.; Orser, B.A.; Dudek, E.; Browning, M.D.; Macdonald, J.F. G-protein-coupled receptors act via protein kinase C and Src to regulate NMDA receptors. Nat. Neurosci., 1999, 2(4), 331-338
96. Alagarsamy, S.; Marino, M.J.; Rouse, S.T.; Gereau, R.W.; Heinemann, S.F.; Conn, P.J. Activation of NMDA receptors reverses desensitization of mGluR5 in native and recombinant systems. Nat. Neurosci., 1999, 2(3), 234-240
97. Heidinger, V.; Manzerra, P.; Wang, X.Q.; Strasser, U.; Yu, S.P.; Choi, D.W.; Behrens, M.M. Metabotropic glutamate receptor 1-induced upregulation of NMDA receptor current: mediation through the Pyk2/Src-family kinase pathway in cortical neurons. J. Neurosci., 2002, 22(13), 5452-5461
98. Yuan, J.P.; Kiselyov, K.; Shin, D.M.; Chen, J.; Shcheynikov, N.; Kang, S.H.; Dehoff, M.H.; Schwarz, M.K.; Seeburg, P.H.; Muallem, S.; Worley, P.F. Homer binds TRPC family channels and is required for gating of TRPC1 by IP3 receptors. Cell, 2003, 114(6), 777-789
99. Husi, H.; Ward, M.A.; Choudhary, J.S.; Blackstock, W.P.; Grant, S.G. Proteomic analysis of NMDA receptor-adhesion protein signaling complexes. Nat. Neurosci., 2000, 3(7), 661-669
100. Kammermeier, P.J.; Xiao, B.; Tu, J.C.; Worley, P.F.; Ikeda, S.R. Homer proteins regulate coupling of group I metabotropic glutamate receptors to N-type calcium and M-type potassium channels. J. Neurosci., 2000, 20(19), 7238-7245
101. Rong, R.; Ahn, J.Y.; Huang, H.; Nagata, E.; Kalman, D.; Kapp, J.A.; Tu, J.; Worley, P.F.; Snyder, S.H.; Ye, K. PI3 kinase enhancer-Homer complex couples mGluRI to PI3 kinase, preventing neuronal apoptosis. Nat. Neurosci., 2003, 6(11), 1153-1161
102. Hou, L.; Klann, E. Activation of the phosphoinositide 3-kinase-Akt-mammalian target of rapamycin signaling pathway is required for metabotropic glutamate receptor-dependent long-term depression. J. Neurosci., 2004, 24(28), 6352-6361
103. Choe, E.S.; Wang, J.Q. Group I metabotropic glutamate receptor activation increases phosphorylation of cAMP response element-binding protein, Elk-1, and extracellular signal-regulated kinases in rat dorsal striatum. Brain Res. Mol. Brain Res., 2001, 94(1-2), 75-84
104. Mao, L.; Yang, L.; Tang, Q.; Samdani, S.; Zhang, G.; Wang, J.Q. The scaffold protein Homer1b/c links metabotropic glutamate receptor 5 to extracellular signal-regulated protein kinase cascades in neurons. J. Neurosci., 2005, 25(10), 2741-2752
105. Nicodemo, A.A.; Pampillo, M.; Ferreira, L.T.; Dale, L.D.; Cregan, T.; Ribeiro, F.M.; Ferguson, S.S.G. Pyk2 uncouples metabotropic glutamate receptor G protein signaling but facilitates ERK1/2 activation. Mol. Brain, 2010, 3(1), 4
106. Yang, L.; Mao, L.; Tang, Q.; Samdani, S.; Liu, Z.; Wang, J.Q. A novel Ca2+-independent signaling pathway to extracellular signal-regulated protein kinase by coactivation of NMDA receptors and metabotropic glutamate receptor 5 in neurons. J. Neurosci., 2004, 24(48), 10846-10857
107. Tappe, A.; Klugmann, M.; Luo, C.; Hirlinger, D.; Agarwal, N.; Benrath, J.; Ehrengruber, M.U.; During, M.J.; Kuner, R. Synaptic scaffolding protein Homer1a protects against chronic inflammatory pain. Nat. Med., 2006, 12(6), 677-681
108. Ronesi, J.A.; Huber, K.M. Homer interactions are necessary for metabotropic glutamate receptor-induced long-term depression and translational activation. J. Neurosci., 2008, 28(2), 543-547
109. Thandi, S.; Blank, J.L.; Challiss, R.A. Group-I metabotropic glutamate receptors, mGlu1a and mGlu5a, couple to extracellular signal-regulated kinase (ERK) activation via distinct, but overlapping, signalling pathways. J. Neurochem., 2002, 83(5), 1139-1153
110. Peavy, R.D.; Chang, M.S.; Sanders-Bush, E.; Conn, P.J. Metabotropic glutamate receptor 5-induced phosphorylation of extracellular signal-regulated kinase in astrocytes depends on transactivation of the epidermal growth factor receptor. J. Neurosci., 2001, 21(24), 9619-9628
111. Luttrell, L.M.; la Rocca, G.J.; van, B.T.; Luttrell, D.K.; Lefkowitz, R.J. Gbetagamma subunits mediate Src-dependent phosphorylation of the epidermal growth factor receptor. A scaffold for G protein-coupled receptor-mediated Ras activation. J. Biol. Chem., 1997, 272(7), 4637-4644
112. Mao, L.; Yang, L.; Arora, A.; Choe, E.S.; Zhang, G.; Liu, Z.; Fibuch, E.E.; Wang, J.Q. Role of protein phosphatase 2A in mGluR5-regulated MEK/ERK phosphorylation in neurons. J. Biol. Chem., 2005, 280(13), 12602-12610
113. Zhang, J.; Cheng, S.; Xiong, Y.; Ma, Y.; Luo, D.; Jeromin, A.; Zhang, H.; He, J. A novel association of mGluR1a with the PDZ scaffold protein CAL modulates receptor activity. FEBS Lett., 2008, 582(30), 4117-4124
114. Meli, E.; Baronti, R.; Pangallo, M.; Picca, R.; Moroni, F.; Pellegrini-Giampietro, D.E. Group I metabotropic glutamate receptors stimulate the activity of poly(ADP-ribose) polymerase in mammalian mGlu1-transfected cells and in cortical cell cultures. Neuropharmacology, 2005, 49(Suppl 1), 80-88
115. Dale, L.B.; Bhattacharya, M.; Anborgh, P.H.; Murdoch, B.; Bhatia, M.; Nakanishi, S.; Ferguson, S.S. G protein-coupled receptor kinase-mediated desensitization of metabotropic glutamate receptor 1A protects against cell death. J. Biol. Chem., 2000, 275(49), 38213-38220
116. Heuss, C.; Gerber, U. G-protein-independent signaling by G-protein-coupled receptors. Trends Neurosci., 2000, 23(10), 469-475
117. Kanumilli, S.; Toms, N.J.; Venkateswarlu, K.; Mellor, H.; Roberts, P.J. Functional coupling of rat metabotropic glutamate 1a receptors to phospholipase D in CHO cells: involvement of extracellular Ca2+, protein kinase C, tyrosine kinase and Rho-A. Neuropharmacology, 2002, 42(1), 1-8
118. Servitja, J.M.; Masgrau, R.; Pardo, R.; Sarri, E.; von Eichel-Streiber, C.; Gutkind, J.S.; Picatoste, F. Metabotropic glutamate receptors activate phospholipase D in astrocytes through a protein kinase C-dependent and Rho-independent pathway. Neuropharmacology, 2003, 44(2), 171-180
119. Bhattacharya, M.; Babwah, A.V.; Godin, C.; Anborgh, P.H.; Dale, L.B.; Poulter, M.O.; Ferguson, S.S. Ral and phospholipase D2-dependent pathway for constitutive metabotropic glutamate receptor endocytosis. J. Neurosci., 2004, 24(40), 8752-8761
120. Hirose, M.; Kitano, J.; Nakajima, Y.; Moriyoshi, K.; Yanagi, S.; Yamamura, H.; Muto, T.; Jingami, H.; Nakanishi, S. Phosphorylation and recruitment of Syk by immunoreceptor tyrosine-based activation motif-based phosphorylation of tamalin. J. Biol. Chem., 2004, 279(31), 32308-32315
121. Wang, J.Q.; Fibuch, E.E.; Mao, L. Regulation of mitogen-activated protein kinases by glutamate receptors. J. Neurochem., 2007, 100(1), 1-11
122. Rodriguez-Moreno, A.; Sistiaga, A.; Lerma, J.; Sanchez-Prieto, J. Switch from facilitation to inhibition of excitatory synaptic transmission by group I mGluR desensitization. Neuron, 1998, 21(6), 1477-1486
123. Ferguson, S.S. Phosphorylation-independent attenuation of GPCR signalling. Trends Pharmacol. Sci., 2007, 28(4), 173-179
124. Ferguson, S.S. Evolving concepts in G protein-coupled receptor endocytosis: the role in receptor desensitization and signaling. Pharmacol. Rev., 2001, 53(1), 1-24
125. Dohlman, H.G.; Thorner, J. RGS proteins and signaling by heterotrimeric G proteins. J. Biol. Chem., 1997, 272(7), 3871-3874
126. Siderovski, D.P.; Strockbine, B.; Behe, C.I. Whither goest the RGS proteins? Crit. Rev. Biochem. Mol. Biol., 1999, 34(4), 215-251
127. Kammermeier, P.J.; Ikeda, S.R. Expression of RGS2 alters the coupling of metabotropic glutamate receptor 1a to M-type K+ and N-type Ca2+ channels. Neuron, 1999, 22(4), 819-829
128. Saugstad, J.A.; Marino, M.J.; Folk, J.A.; Hepler, J.R.; Conn, P.J. RGS4 inhibits signaling by group I metabotropic glutamate receptors. J. Neurosci., 1998, 18(3), 905-913
129. Catania, M.V.; Aronica, E.; Sortino, M.A.; Canonico, P.L.; Nicoletti, F. Desensitization of metabotropic glutamate receptors in neuronal cultures. J. Neurochem., 1991, 56(4), 1329-1335
130. Mundell, S.J.; Pula, G.; McIlhinney, R.A.; Roberts, P.J.; Kelly, E. Desensitization and internalization of metabotropic glutamate receptor 1a following activation of heterologous Gq/11-coupled receptors. Biochemistry, 2004, 43(23), 7541-7551
131. Sallese, M.; Salvatore, L.; D'Urbano, E.; Sala, G.; Storto, M.; Launey, T.; Nicoletti, F.; Knopfel, T.; De, B.A. The G-protein-coupled receptor kinase GRK4 mediates homologous desensitization of metabotropic glutamate receptor 1. FASEB J., 2000, 14(15), 2569-2580
132. Ribeiro, F.M.; Ferreira, L.T.; Paquet, M.; Cregan, T.; Ding, Q.; Gros, R.; Ferguson, S.S. Phosphorylation-independent regulation of metabotropic glutamate receptor 5 desensitization and internalization by G protein-coupled receptor kinase 2 in neurons. J. Biol. Chem., 2009, 284(35), 23444-23453
133. Dhami, G.K.; Anborgh, P.H.; Dale, L.B.; Sterne-Marr, R.; Ferguson, S.S. Phosphorylation-independent regulation of metabotropic glutamate receptor signaling by G protein-coupled receptor kinase 2. J. Biol. Chem., 2002, 277(28), 25266-25272
134. Carman, C.V.; Parent, J.L.; Day, P.W.; Pronin, A.N.; Sternweis, P.M.; Wedegaertner, P.B.; Gilman, A.G.; Benovic, J.L.; Kozasa, T. Selective regulation of Galpha(q/11) by an RGS domain in the G protein-coupled receptor kinase, GRK2. J. Biol. Chem., 1999, 274(48), 34483-34492
135. Sorensen, S.D.; Conn, P.J. G protein-coupled receptor kinases regulate metabotropic glutamate receptor 5 function and expression. Neuropharmacology, 2003, 44(6), 699-706
136. Mundell, S.J.; Pula, G.; Carswell, K.; Roberts, P.J.; Kelly, E. Agonist-induced internalization of metabotropic glutamate receptor 1A: structural determinants for protein kinase C-and G protein-coupled receptor kinase-mediated internalization. J. Neurochem., 2003, 84(2), 294-304
137. Anborgh, P.H.; Godin, C.; Pampillo, M.; Dhami, G.K.; Dale, L.B.; Cregan, S.P.; Truant, R.; Ferguson, S.S. Inhibition of metabotropic glutamate receptor signaling by the huntingtin-binding protein optineurin. J. Biol. Chem., 2005, 280(41), 34840-34848
138. Ferreira, L.T.; Dale, L.B.; Ribeiro, F.M.; Babwah, A.V.; Pampillo, M.; Ferguson, S.S. Calcineurin inhibitor protein (CAIN) attenuates Group I metabotropic glutamate receptor endocytosis and signaling. J. Biol. Chem., 2009, 284(42), 28986-28994
139. Dale, L.B.; Bhattacharya, M.; Seachrist, J.L.; Anborgh, P.H.; Ferguson, S.S. Agonist-stimulated and tonic internalization of metabotropic glutamate receptor 1a in human embryonic kidney 293 cells: agonist-stimulated endocytosis is beta-arrestin1 isoform-specific. Mol. Pharmacol., 2001, 60(6), 1243-1253
140. Luis, A.J.; Fernandez, M.; Martin, M. Internalization of metabotropic glutamate receptor in C6 cells through clathrin-coated vesicles. Brain Res. Mol. Brain Res., 2002, 99(1), 54-66
141. Pula, G.; Mundell, S.J.; Roberts, P.J.; Kelly, E. Agonist-independent internalization of metabotropic glutamate receptor 1a is arrestin-and clathrin-dependent and is suppressed by receptor inverse agonists. J. Neurochem., 2004, 89(4), 1009-1020
142. Mundell, S.J.; Matharu, A.L.; Pula, G.; Roberts, P.J.; Kelly, E. Agonist-induced internalization of the metabotropic glutamate receptor 1a is arrestin-and dynamin-dependent. J. Neurochem., 2001, 78(3), 546-551
143. Fourgeaud, L.; Bessis, A.S.; Rossignol, F.; Pin, J.P.; Olivo-Marin, J.C.; Hemar, A. The metabotropic glutamate receptor mGluR5 is endocytosed by a clathrin-independent pathway. J. Biol. Chem., 2003, 278(14), 12222-12230
144. Jones, D.; Morgan, C.; Cockcroft, S. Phospholipase D and membrane traffic.Potential roles in regulated exocytosis, membrane delivery and vesicle budding. Biochim. Biophys. Acta, 1999, 1439(2), 229-244
145. Conn, P.J.; Lindsley, C.W.; Jones, C.K. Activation of metabotropic glutamate receptors as a novel approach for the treatment of schizophrenia. Trends Pharmacol. Sci., 2009, 30(1), 25-31
146. Brody, S.A.; Dulawa, S.C.; Conquet, F.; Geyer, M.A. Assessment of a prepulse inhibition deficit in a mutant mouse lacking mGlu5 receptors. Mol. Psychiatry, 2004, 9(1), 35-41
147. Kinney, G.G.; Burno, M.; Campbell, U.C.; Hernandez, L.M.; Rodriguez, D.; Bristow, L.J.; Conn, P.J. Metabotropic glutamate subtype 5 receptors modulate locomotor activity and sensorimotor gating in rodents. J. Pharmacol. Exp. Ther., 2003, 306(1), 116-123
148. Campbell, U.C.; Lalwani, K.; Hernandez, L.; Kinney, G.G.; Conn, P.J.; Bristow, L.J. The mGluR5 antagonist 2-methyl-6-(phenylethynyl)-pyridine (MPEP) potentiates PCP-induced cognitive deficits in rats. Psychopharmacology (Berl.), 2004, 175(3), 310-318
149. Aron, C.; Simon, P.; Larousse, C.; Boissier, J.R. Evaluation of a rapid technique for detecting minor tranquilizers. Neuropharmacology, 1971, 10(4), 459-469
150. Cryan, J.F.; Mombereau, C.; Vassout, A. The tail suspension test as a model for assessing antidepressant activity: review of pharmacological and genetic studies in mice. Neurosci. Biobehav. Rev., 2005, 29(4-5), 571-625
151. Belozertseva, I.V.; Kos, T.; Popik, P.; Danysz, W.; Bespalov, A.Y. Antidepressant-like effects of mGluR1 and mGluR5 antagonists in the rat forced swim and the mouse tail suspension tests. Eur. Neuropsychopharmacol., 2007, 17(3), 172-179
152. Li, X.; Need, A.B.; Baez, M.; Witkin, J.M. Metabotropic glutamate 5 receptor antagonism is associated with antidepressant-like effects in mice. J. Pharmacol. Exp. Ther., 2006, 319(1), 254-259
153. Spooren, W.P.; Vassout, A.; Neijt, H.C.; Kuhn, R.; Gasparini, F.; Roux, S.; Porsolt, R.D.; Gentsch, C. Anxiolytic-like effects of the prototypical metabotropic glutamate receptor 5 antagonist 2-methyl-6-(phenylethynyl)pyridine in rodents. J. Pharmacol. Exp. Ther., 2000, 295(3), 1267-1275
154. Tatarczynska, E.; Klodzinska, A.; Chojnacka-Wojcik, E.; Palucha, A.; Gasparini, F.; Kuhn, R.; Pilc, A. Potential anxiolytic-and antidepressant-like effects of MPEP, a potent, selective and systemically active mGlu5 receptor antagonist. Br. J. Pharmacol., 2001, 132(7), 1423-1430
155. Schulz, B.; Fendt, M.; Gasparini, F.; Lingenhohl, K.; Kuhn, R.; Koch, M. The metabotropic glutamate receptor antagonist 2-methyl-6-(phenylethynyl)-pyridine (MPEP) blocks fear conditioning in rats. Neuropharmacology, 2001, 41(1), 1-7
156. Pietraszek, M.; Sukhanov, I.; Maciejak, P.; Szyndler, J.; Gravius, A.; Wislowska, A.; Plaznik, A.; Bespalov, A.Y.; Danysz, W. Anxiolytic-like effects of mGlu1 and mGlu5 receptor antagonists in rats. Eur. J. Pharmacol., 2005, 514(1), 25-34
157. Brodkin, J.; Bradbury, M.; Busse, C.; Warren, N.; Bristow, L.J.; Varney, M.A. Reduced stress-induced hyperthermia in mGluR5 knockout mice. Eur. J. Neurosci., 2002, 16(11), 2241-2244
158. Tatarczynska, E.; Klodzinska, A.; Kroczka, B.; Chojnacka-Wojcik, E.; Pilc, A. The antianxiety-like effects of antagonists of group I and agonists of group II and III metabotropic glutamate receptors after intrahippocampal administration. Psychopharmacology (Berl.), 2001, 158(1), 94-99
159. Rorick-Kehn, L.M.; Hart, J.C.; McKinzie, D.L. Pharmacological characterization of stress-induced hyperthermia in DBA/2 mice using metabotropic and ionotropic glutamate receptor ligands. Psychopharmacology (Berl.), 2005, 183(2), 226-240
160. Oka, A.; Takashima, S. The up-regulation of metabotropic glutamate receptor 5 (mGluR5) in Down's syndrome brains. Acta Neuropathol., 1999, 97(3), 275-278
161. Dalfo, E.; Albasanz, J.L.; Rodriguez, A.; Martin, M.; Ferrer, I. Abnormal group I metabotropic glutamate receptor expression and signaling in the frontal cortex in Pick disease. J. Neuropathol. Exp. Neurol., 2005, 64(7), 638-647
162. Sims, N.R.; Muyderman, H. Mitochondria, oxidative metabolism and cell death in stroke. Biochim. Biophys. Acta, 2010, 1802(1), 80-91
163. Sugawara, T.; Chan, P.H. Reactive oxygen radicals and pathogenesis of neuronal death after cerebral ischemia 7. Antioxid. Redox. Signal., 2003, 5(5), 597-607
164. Mattson, M.P.; Culmsee, C.; Yu, Z.F. Apoptotic and antiapoptotic mechanisms in stroke 19. Cell Tissue Res., 2000, 301(1), 173-187
165. Turley, K.R.; Toledo-Pereyra, L.H.; Kothari, R.U. Molecular mechanisms in the pathogenesis and treatment of acute ischemic stroke. J. Invest. Surg., 2005, 18(4), 207-218
166. Pellegrini-Giampietro, D.E.; Peruginelli, F.; Meli, E.; Cozzi, A.; bani-Torregrossa, S.; Pellicciari, R.; Moroni, F. Protection with metabotropic glutamate 1 receptor antagonists in models of ischemic neuronal death: time-course and mechanisms. Neuropharmacology, 1999, 38(10), 1607-1619
167. De, V.J.; Horvath, E.; Schreiber, R. Neuroprotective and behavioral effects of the selective metabotropic glutamate mGlu(1) receptor antagonist BAY 36-7620. Eur. J. Pharmacol., 2001, 428(2), 203-214
168. Cozzi, A.; Meli, E.; Carla, V.; Pellicciari, R.; Moroni, F.; Pellegrini-Giampietro, D.E. Metabotropic glutamate 1 (mGlu1) receptor antagonists enhance GABAergic neurotransmission: a mechanism for the attenuation of post-ischemic injury and epileptiform activity? Neuropharmacology, 2002, 43(2), 119-130
169. Meli, E.; Picca, R.; Attucci, S.; Cozzi, A.; Peruginelli, F.; Moroni, F.; Pellegrini-Giampietro, D.E. Activation of mGlu1 but not mGlu5 metabotropic glutamate receptors contributes to postischemic neuronal injury in vitro and in vivo. Pharmacol. Biochem. Behav., 2002, 73(2), 439-446
170. Murotomi, K.; Takagi, N.; Takayanagi, G.; Ono, M.; Takeo, S.; Tanonaka, K. mGluR1 antagonist decreases tyrosine phosphorylation of NMDA receptor and attenuates infarct size after transient focal cerebral ischemia. J. Neurochem., 2008, 105(5), 1625-1634
171. Kohara, A.; Takahashi, M.; Yatsugi, S.; Tamura, S.; Shitaka, Y.; Hayashibe, S.; Kawabata, S.; Okada, M.Neuroprotective effects of the selective type 1 metabotropic glutamate receptor antagonist YM-202074 in rat stroke models. Brain Res., 2008, 1191, 168-179
172. Szydlowska, K.; Kaminska, B.; Baude, A.; Parsons, C.G.; Danysz, W. Neuroprotective activity of selective mGlu1 and mGlu5 antagonists in vitro and in vivo. Eur. J. Pharmacol., 2007, 554(1), 18-29
173. Ferraguti, F.; Pietra, C.; Valerio, E.; Corti, C.; Chiamulera, C.; Conquet, F. Evidence against a permissive role of the metabotropic glutamate receptor 1 in acute excitotoxicity. Neuroscience, 1997, 79(1), 1-5
174. Werner, C.G.; Scartabelli, T.; Pancani, T.; Landucci, E.; Moroni, F.; Pellegrini-Giampietro, D.E. Differential role of mGlu1 and mGlu5 receptors in rat hippocampal slice models of ischemic tolerance. Eur. J. Neurosci., 2007, 25(12), 3597-3604
175. Schroder, U.H.; Opitz, T.; Jager, T.; Sabelhaus, C.F.; Breder, J.; Reymann, K.G. Protective effect of group I metabotropic glutamate receptor activation against hypoxic/hypoglycemic injury in rat hippocampal slices: timing and involvement of protein kinase C. Neuropharmacology, 1999, 38(2), 209-216
176. Allen, J.W.; Knoblach, S.M.; Faden, A.I. Activation of group I metabotropic glutamate receptors reduces neuronal apoptosis but increases necrotic cell death in vitro. Cell Death Differ., 2000, 7(5), 470-476
177. Moroni, F.; Attucci, S.; Cozzi, A.; Meli, E.; Picca, R.; Scheideler, M.A.; Pellicciari, R.; Noe, C.; Sarichelou, I.; Pellegrini-Giampietro, D.E. The novel and systemically active metabotropic glutamate 1 (mGlu1) receptor antagonist 3-MATIDA reduces post-ischemic neuronal death. Neuropharmacology, 2002, 42(6), 741-751
178. Allen, J.W.; Vicini, S.; Faden, A.I. Exacerbation of neuronal cell death by activation of group I metabotropic glutamate receptors: role of NMDA receptors and arachidonic acid release. Exp. Neurol., 2001, 169(2), 449-460
179. Bruno, V.; Battaglia, G.; Copani, A.; Cespedes, V.M.; Galindo, M.F.; Cena, V.; Sanchez-Prieto, J.; Gasparini, F.; Kuhn, R.; Flor, P.J.; Nicoletti, F. An activity-dependent switch from facilitation to inhibition in the control of excitotoxicity by group I metabotropic glutamate receptors. Eur. J. Neurosci., 2001, 13(8), 1469-1478
180. Blaabjerg, M.; Fang, L.; Zimmer, J.; Baskys, A. Neuroprotection against NMDA excitotoxicity by group I metabotropic glutamate receptors is associated with reduction of NMDA stimulated currents. Exp. Neurol., 2003, 183(2), 573-580
181. Awad, H.; Hubert, G.W.; Smith, Y.; Levey, A.I.; Conn, P.J. Activation of metabotropic glutamate receptor 5 has direct excitatory effects and potentiates NMDA receptor currents in neurons of the subthalamic nucleus. J. Neurosci., 2000, 20(21), 7871-7879
182. Skeberdis, V.A.; Lan, J.; Opitz, T.; Zheng, X.; Bennett, M.V.; Zukin, R.S. mGluR1-mediated potentiation of NMDA receptors involves a rise in intracellular calcium and activation of protein kinase C. Neuropharmacology, 2001, 40(7), 856-865
183. Kalda, A.; Kaasik, A.; Vassiljev, V.; Pokk, P.; Zharkovsky, A. Neuroprotective action of group I metabotropic glutamate receptor agonists against oxygen-glucose deprivation-induced neuronal death. Brain Res., 2000, 853(2), 370-373
184. Vincent, A.M.; Mohammad, Y.; Ahmad, I.; Greenberg, R.; Maiese, K. Metabotropic glutamate receptors prevent nitric oxide-induced programmed cell death. J. Neurosci. Res., 1997, 50(4), 549-564
185. Sagara, Y.; Schubert, D. The activation of metabotropic glutamate receptors protects nerve cells from oxidative stress. J. Neurosci., 1998, 18(17), 6662-6671
186. Scartabelli, T.; Gerace, E.; Landucci, E.; Moroni, F.; Pellegrini-Giampietro, D.E. Neuroprotection by group I mGlu receptors in a rat hippocampal slice model of cerebral ischemia is associated with the PI3K-Akt signaling pathway: a novel postconditioning strategy? Neuropharmacology, 2008, 55(4), 509-516
187. Xu, W.; Wong, T.P.; Chery, N.; Gaertner, T.; Wang, Y.T.; Baudry, M. Calpain-mediated mGluR1alpha truncation: a key step in excitotoxicity. Neuron, 2007, 53(3), 399-412
188. Zhou, M.; Xu, W.; Liao, G.; Bi, X.; Baudry, M. Neuroprotection against neonatal hypoxia/ischemia-induced cerebral cell death by prevention of calpain-mediated mGluR1alpha truncation. Exp. Neurol., 2009, 218(1), 75-82
189. Bao, W.L.; Williams, A.J.; Faden, A.I.; Tortella, F.C. Selective mGluR5 receptor antagonist or agonist provides neuroprotection in a rat model of focal cerebral ischemia. Brain Res., 2001, 922(2), 173-179
190. Hampson, D.R.; Theriault, E.; Huang, X.P.; Kristensen, P.; Pickering, D.S.; Franck, J.E.; Mulvihill, E.R. Characterization of two alternatively spliced forms of a metabotropic glutamate receptor in the central nervous system of the rat. Neuroscience, 1994, 60(2), 325-336
191. Lujan, R.; Nusser, Z.; Roberts, J.D.; Shigemoto, R.; Somogyi, P. Perisynaptic location of metabotropic glutamate receptors mGluR1 and mGluR5 on dendrites and dendritic spines in the rat hippocampus. Eur. J. Neurosci., 1996, 8(7), 1488-1500
192. Bassell, G.J.; Warren, S.T. Fragile X syndrome: loss of local mRNA regulation alters synaptic development and function. Neuron, 2008, 60(2), 201-214
193. Verkerk, A.J.; Pieretti, M.; Sutcliffe, J.S.; Fu, Y.H.; Kuhl, D.P.; Pizzuti, A.; Reiner, O.; Richards, S.; Victoria, M.F.; Zhang, F.P. Identification of a gene (FMR-1) containing a CGG repeat coincident with a breakpoint cluster region exhibiting length variation in fragile X syndrome. Cell, 1991, 65(5), 905-914
194. Ashley, C.T., Jr.; Wilkinson, K.D.; Reines, D.; Warren, S.T. FMR1 protein: conserved RNP family domains and selective RNA binding. Science, 1993, 262(5133), 563-566
195. Lu, R.; Wang, H.; Liang, Z.; Ku, L.; O'donnell, W.T.; Li, W.; Warren, S.T.; Feng, Y. The fragile X protein controls microtubule-associated protein 1B translation and microtubule stability in brain neuron development. Proc. Natl. Acad. Sci. USA, 2004, 101(42), 15201-15206
196. Zalfa, F.; Giorgi, M.; Primerano, B.; Moro, A.; Di, P.A.; Reis, S.; Oostra, B.; Bagni, C. The fragile X syndrome protein FMRP associates with BC1 RNA and regulates the translation of specific mRNAs at synapses. Cell, 2003, 112(3), 317-327
197. Huber, K.M.; Kayser, M.S.; Bear, M.F. Role for rapid dendritic protein synthesis in hippocampal mGluR-dependent long-term depression. Science, 2000, 288(5469), 1254-1257
198. Dolen, G.; Bear, M.F. Role for metabotropic glutamate receptor 5 (mGluR5) in the pathogenesis of fragile X syndrome. J. Physiol., 2008, 586(6), 1503-1508
199. Yan, Q.J.; Rammal, M.; Tranfaglia, M.; Bauchwitz, R.P. Suppression of two major Fragile X Syndrome mouse model phenotypes by the mGluR5 antagonist MPEP. Neuropharmacology, 2005, 49(7), 1053-1066
200. Klann, E.; Dever, T.E. Biochemical mechanisms for translational regulation in synaptic plasticity. Nat. Rev. Neurosci., 2004, 5(12), 931-942
201. Banko, J.L.; Hou, L.; Poulin, F.; Sonenberg, N.; Klann, E. Regulation of eukaryotic initiation factor 4E by converging signaling pathways during metabotropic glutamate receptor-dependent long-term depression. J. Neurosci., 2006, 26(8), 2167-2173
202. Wang, H.; Fukushima, H.; Kida, S.; Zhuo, M. Ca2+/calmodulin-dependent protein kinase IV links group I metabotropic glutamate receptors to fragile X mental retardation protein in cingulate cortex. J. Biol. Chem., 2009, 284(28), 18953-18962
203. Greenough, W.T.; Klintsova, A.Y.; Irwin, S.A.; Galvez, R.; Bates, K.E.; Weiler, I.J. Synaptic regulation of protein synthesis and the fragile X protein. Proc. Natl. Acad. Sci. USA, 2001, 98(13), 7101-7106
204. Muddashetty, R.S.; Kelic, S.; Gross, C.; Xu, M.; Bassell, G.J. Dysregulated metabotropic glutamate receptor-dependent translation of AMPA receptor and postsynaptic density-95 mRNAs at synapses in a mouse model of fragile X syndrome. J. Neurosci., 2007, 27(20), 5338-5348
205. Narayanan, U.; Nalavadi, V.; Nakamoto, M.; Pallas, D.C.; Ceman, S.; Bassell, G.J.; Warren, S.T. FMRP phosphorylation reveals an immediate-early signaling pathway triggered by group I mGluR and mediated by PP2A. J. Neurosci., 2007, 27(52), 14349-14357
206. Giuffrida, R.; Musumeci, S.; D'Antoni, S.; Bonaccorso, C.M.; Giuffrida-Stella, A.M.; Oostra, B.A.; Catania, M.V. A reduced number of metabotropic glutamate subtype 5 receptors are associated with constitutive homer proteins in a mouse model of fragile X syndrome. J. Neurosci., 2005, 25(39), 8908-8916
207. Keele, N.B.; Neugebauer, V.; Shinnick-Gallagher, P. Differential effects of metabotropic glutamate receptor antagonists on bursting activity in the amygdala. J. Neurophysiol., 1999, 81(5), 2056-2065
208. Stoop, R.; Conquet, F.; Pralong, E. Determination of group I metabotropic glutamate receptor subtypes involved in the frequency of epileptiform activity in vitro using mGluR1 and mGluR5 mutant mice. Neuropharmacology, 2003, 44(2), 157-162
209. Thomsen, C.; Klitgaard, H.; Sheardown, M.; Jackson, H.C.; Eskesen, K.; Jacobsen, P.; Treppendahl, S.; Suzdak, P.D. (S)-4-carboxy-3-hydroxyphenylglycine, an antagonist of metabotropic glutamate receptor (mGluR) 1a and an agonist of mGluR2, protects against audiogenic seizures in DBA/2 mice. J. Neurochem., 1994, 62(6), 2492-2495
210. Chapman, A.G.; Yip, P.K.; Yap, J.S.; Quinn, L.P.; Tang, E.; Harris, J.R.; Meldrum, B.S. Anticonvulsant actions of LY 367385 ((+)-2-methyl-4-carboxyphenylglycine) and AIDA ((RS)-1-aminoindan-1,5-dicarboxylic acid). Eur. J. Pharmacol., 1999, 368(1), 17-24
211. Pitsch, J.; Schoch, S.; Gueler, N.; Flor, P.J.; van der, P.H.; Becker, A.J. Functional role of mGluR1 and mGluR4 in pilocarpine-induced temporal lobe epilepsy. Neurobiol. Dis., 2007, 26(3), 623-633
212. Chapman, A.G.; Nanan, K.; Williams, M.; Meldrum, B.S. Anticonvulsant activity of two metabotropic glutamate group I antagonists selective for the mGlu5 receptor: 2-methyl-6-(phenylethynyl)-pyridine (MPEP), and (E)-6-methyl-2-styryl-pyridine (SIB 1893). Neuropharmacology, 2000, 39(9), 1567-1574
213. Merlin, L.R. Differential roles for mGluR1 and mGluR5 in the persistent prolongation of epileptiform bursts. J. Neurophysiol., 2002, 87(1), 621-625
214. Tang, F.R. Agonists and antagonists of metabotropic glutamate receptors: anticonvulsants and antiepileptogenic agents? Curr. Neuropharmacol., 2005, 3(4), 299-307
215. Ure, J.; Baudry, M.; Perassolo, M. Metabotropic glutamate receptors and epilepsy. J. Neurol. Sci., 2006, 247(1), 1-9
216. Notenboom, R.G.; Hampson, D.R.; Jansen, G.H.; van Rijen, P.C.; van Veelen, C.W.; van, N.O.; de Graan, P.N. Up-regulation of hippocampal metabotropic glutamate receptor 5 in temporal lobe epilepsy patients. Brain, 2006, 129(Pt 1), 96-107
217. Akbar, M.T.; Rattray, M.; Powell, J.F.; Meldrum, B.S. Altered expression of group I metabotropic glutamate receptors in the hippocampus of amygdala-kindled rats. Brain Res. Mol. Brain Res., 1996, 43(1-2), 105-116
218. Merlin, L.R.; Wong, R.K. Role of group I metabotropic glutamate receptors in the patterning of epileptiform activities in vitro. J. Neurophysiol., 1997, 78(1), 539-544
219. Chuang, S.C.; Bianchi, R.; Kim, D.; Shin, H.S.; Wong, R.K. Group I metabotropic glutamate receptors elicit epileptiform discharges in the hippocampus through PLCbeta1 signaling. J. Neurosci., 2001, 21(16), 6387-6394
220. Lieb, J.P.; Engel, J., Jr.; Gevins, A.; Crandal, P.H. Surface and deep EEG correlates of surgical outcome in temporal lobe epilepsy. Epilepsia, 1981, 22(5), 515-538
221. Lieb, J.P.; Engel, J., Jr.; Brown, W.J.; Gevins, A.S.; Crandall, P.H. Neuropathological findings following temporal lobectomy related to surface and deep EEG patterns. Epilepsia, 1981, 22(5), 539-549
222. Taylor, G.W.; Merlin, L.R.; Wong, R.K. Synchronized oscillations in hippocampal CA3 neurons induced by metabotropic glutamate receptor activation. J. Neurosci., 1995, 15(12), 8039-8052
223. Anwyl, R. Metabotropic glutamate receptors: electrophysiological properties and role in plasticity. Brain Res. Brain Res. Rev., 1999, 29(1), 83-120
224. Wong, R.K.; Prince, D.A. Afterpotential generation in hippocampal pyramidal cells. J. Neurophysiol., 1981, 45(1), 86-97
225. Chuang, S.C.; Bianchi, R.; Wong, R.K. Group I mGluR activation turns on a voltage-gated inward current in hippocampal pyramidal cells. J. Neurophysiol., 2000, 83(5), 2844-2853
226. Wong, R.K.; Chuang, S.C.; Bianchi, R. Plasticity mechanisms underlying mGluR-induced epileptogenesis. Adv. Exp. Med. Biol., 2004, 548, 69-75
227. Bianchi, R.; Chuang, S.C.; Zhao, W.; Young, S.R.; Wong, R.K. Cellular plasticity for group I mGluR-mediated epileptogenesis. J. Neurosci., 2009, 29(11), 3497-3507
228. Merlin, L.R.; Bergold, P.J.; Wong, R.K. Requirement of protein synthesis for group I mGluR-mediated induction of epileptiform discharges. J. Neurophysiol., 1998, 80(2), 989-993
229. Zhao, W.; Bianchi, R.; Wang, M.; Wong, R.K. Extracellular signal-regulated kinase 1/2 is required for the induction of group I metabotropic glutamate receptor-mediated epileptiform discharges. J. Neurosci., 2004, 24(1), 76-84
230. Martin, E.D.; Araque, A.; Buno, W. Synaptic regulation of the slow Ca2+-activated K+ current in hippocampal CA1 pyramidal neurons: implication in epileptogenesis. J. Neurophysiol., 2001, 86(6), 2878-2886
231. Young, S.R.; Chuang, S.C.; Wong, R.K. Modulation of afterpotentials and firing pattern in guinea pig CA3 neurones by group I metabotropic glutamate receptors. J. Physiol., 2004, 554(Pt 2), 371-385
232. Young, S.R.; Bianchi, R.; Wong, R.K. Signaling mechanisms underlying group I mGluR-induced persistent AHP suppression in CA3 hippocampal neurons. J. Neurophysiol., 2008, 99(3), 1105-1118
233. Krause, M.; Offermanns, S.; Stocker, M.; Pedarzani, P. Functional specificity of G alpha q and G alpha 11 in the cholinergic and glutamatergic modulation of potassium currents and excitability in hippocampal neurons. J. Neurosci., 2002, 22(3), 666-673
234. Heuss, C.; Scanziani, M.; Gahwiler, B.H.; Gerber, U. G-protein-independent signaling mediated by metabotropic glutamate receptors. Nat. Neurosci., 1999, 2(12), 1070-1077
235. Ireland, D.R.; Abraham, W.C. Group I mGluRs increase excitability of hippocampal CA1 pyramidal neurons by a PLC-independent mechanism. J. Neurophysiol., 2002, 88(1), 107-116
236. Weiler, I.J.; Irwin, S.A.; Klintsova, A.Y.; Spencer, C.M.; Brazelton, A.D.; Miyashiro, K.; Comery, T.A.; Patel, B.; Eberwine, J.; Greenough, W.T. Fragile X mental retardation protein is translated near synapses in response to neurotransmitter activation. Proc. Natl. Acad. Sci. USA, 1997, 94(10), 5395-5400
237. Huber, K.M.; Gallagher, S.M.; Warren, S.T.; Bear, M.F. Altered synaptic plasticity in a mouse model of fragile X mental retardation.Proc. Natl. Acad. Sci. USA, 2002, 99(11), 7746-7750
238. Aschrafi, A.; Cunningham, B.A.; Edelman, G.M.; Vanderklish, P.W. The fragile X mental retardation protein and group I metabotropic glutamate receptors regulate levels of mRNA granules in brain. Proc. Natl. Acad. Sci. USA, 2005, 102(6), 2180-2185
239. Chuang, S.C.; Zhao, W.; Bauchwitz, R.; Yan, Q.; Bianchi, R.; Wong, R.K. Prolonged epileptiform discharges induced by altered group I metabotropic glutamate receptor-mediated synaptic responses in hippocampal slices of a fragile X mouse model. J. Neurosci., 2005, 25(35), 8048-8055
240. Hou, L.; Antion, M.D.; Hu, D.; Spencer, C.M.; Paylor, R.; Klann, E. Dynamic translational and proteasomal regulation of fragile X mental retardation protein controls mGluR-dependent long-term depression. Neuron, 2006, 51(4), 441-454
241. Penagarikano, O.; Mulle, J.G.; Warren, S.T. The pathophysiology of fragile x syndrome. Annu. Rev. Genomics Hum. Genet., 2007, 8, 109-129
242. Li, S.H.; Li, X.J. Huntingtin-protein interactions and the pathogenesis of Huntington's disease. Trends Genet., 2004, 20(3), 146-154
243. Young, A.B. Huntingtin in health and disease. J. Clin. Invest., 2003, 111(3), 299-302
244. Huntington's Disease Collaborative Research Group. A novel gene containing a trinucleotide repeat that is expanded and unstable on Huntington's disease chromosomes.Cell, 1993, 72(6), 971-983
245. Li, S.H.; Schilling, G.; Young, W.S. III; Li, X.J.; Margolis, R.L.; Stine, O.C.; Wagster, M.V.; Abbott, M.H.; Franz, M.L.; Ranen, N.G. Huntington's disease gene (IT15) is widely expressed in human and rat tissues. Neuron, 1993, 11(5), 985-993
246. Strong, T.V.; Tagle, D.A.; Valdes, J.M.; Elmer, L.W.; Boehm, K.; Swaroop, M.; Kaatz, K.W.; Collins, F.S.; Albin, R.L. Widespread expression of the human and rat Huntington's disease gene in brain and nonneural tissues. Nat. Genet., 1993, 5(3), 259-265
247. Chen, N.; Luo, T.; Wellington, C.; Metzler, M.; McCutcheon, K.; Hayden, M.R.; Raymond, L.A. Subtype-specific enhancement of NMDA receptor currents by mutant huntingtin. J. Neurochem., 1999, 72(5), 1890-1898
248. Schiefer, J.; Sprunken, A.; Puls, C.; Luesse, H.G.; Milkereit, A.; Milkereit, E.; Johann, V.; Kosinski, C.M. The metabotropic glutamate receptor 5 antagonist MPEP and the mGluR2 agonist LY379268 modify disease progression in a transgenic mouse model of Huntington's disease. Brain Res., 2004, 1019(1-2), 246-254
249. Zeron, M.M.; Hansson, O.; Chen, N.; Wellington, C.L.; Leavitt, B.R.; Brundin, P.; Hayden, M.R.; Raymond, L.A. Increased sensitivity to N-methyl-D-aspartate receptor-mediated excitotoxicity in a mouse model of Huntington's disease. Neuron, 2002, 33(6), 849-860
250. Beal, M.F.; Kowall, N.W.; Ellison, D.W.; Mazurek, M.F.; Swartz, K.J.; Martin, J.B. Replication of the neurochemical characteristics of Huntington's disease by quinolinic acid. Nature, 1986, 321(6066), 168-171
251. Hantraye, P.; Riche, D.; Maziere, M.; Isacson, O. A primate model of Huntington's disease: behavioral and anatomical studies of unilateral excitotoxic lesions of the caudate-putamen in the baboon. Exp. Neurol., 1990, 108(2), 91-104
252. Zeron, M.M.; Chen, N.; Moshaver, A.; Lee, A.T.; Wellington, C.L.; Hayden, M.R.; Raymond, L.A. Mutant huntingtin enhances excitotoxic cell death. Mol. Cell Neurosci., 2001, 17(1), 41-53
253. Landwehrmeyer, G.B.; Standaert, D.G.; Testa, C.M.; Penney, J.B. Jr.; Young, A.B. NMDA receptor subunit mRNA expression by projection neurons and interneurons in rat striatum. J. Neurosci., 1995, 15(7 Pt 2), 5297-5307
254. Monyer, H.; Burnashev, N.; Laurie, D.J.; Sakmann, B.; Seeburg, P.H. Developmental and regional expression in the rat brain and functional properties of four NMDA receptors. Neuron, 1994, 12(3), 529-540
255. Thompson, C.L.; Drewery, D.L.; Atkins, H.D.; Stephenson, F.A.; Chazot, P.L. Immunohistochemical localization of N-methyl-D-aspartate receptor NR1, NR2A, NR2B and NR2C/D subunits in the adult mammalian cerebellum. Neurosci. Lett., 2000, 283(2), 85-88
256. Calabresi, P.; Centonze, D.; Pisani, A.; Bernardi, G. Metabotropic glutamate receptors and cell-type-specific vulnerability in the striatum: implication for ischemia and Huntington's disease. Exp. Neurol., 1999, 158(1), 97-108
257. Sun, Y.; Savanenin, A.; Reddy, P.H.; Liu, Y.F. Polyglutamine-expanded huntingtin promotes sensitization of N-methyl-D-aspartate receptors via post-synaptic density 95. J. Biol. Chem., 2001, 276(27), 24713-24718
258. Panov, A.V.; Gutekunst, C.A.; Leavitt, B.R.; Hayden, M.R.; Burke, J.R.; Strittmatter, W.J.; Greenamyre, J.T. Early mitochondrial calcium defects in Huntington's disease are a direct effect of polyglutamines. Nat. Neurosci., 2002, 5(8), 731-736
259. Choo, Y.S.; Johnson, G.V.; MacDonald, M.; Detloff, P.J.; Lesort, M. Mutant huntingtin directly increases susceptibility of mitochondria to the calcium-induced permeability transition and cytochrome c release. Hum. Mol. Genet., 2004, 13(14), 1407-1420
260. Tang, T.S.; Slow, E.; Lupu, V.; Stavrovskaya, I.G.; Sugimori, M.; Llinas, R.; Kristal, B.S.; Hayden, M.R.; Bezprozvanny, I. Disturbed Ca2+ signaling and apoptosis of medium spiny neurons in Huntington's disease. Proc. Natl. Acad. Sci. USA, 2005, 102(7), 2602-2607
261. Tang, T.S.; Tu, H.; Chan, E.Y.; Maximov, A.; Wang, Z.; Wellington, C.L.; Hayden, M.R.; Bezprozvanny, I. Huntingtin and huntingtin-associated protein 1 influence neuronal calcium signaling mediated by inositol-(1,4,5) triphosphate receptor type 1. Neuron, 2003, 39(2), 227-239
262. Ribeiro, F.M.; Paquet, M.; Ferreira, L.T.; Cregan, T.; Swan, P.; Cregan, S.P.; Ferguson, S.S. Metabotropic glutamate receptor-mediated cell signaling pathways are altered in a mouse model of Huntington's disease 1. J. Neurosci., 2010, 30(1), 316-324
263. Harjes, P.; Wanker, E.E. The hunt for huntingtin function: interaction partners tell many different stories. Trends Biochem. Sci., 2003, 28(8), 425-433
264. Gines, S.; Ivanova, E.; Seong, I.S.; Saura, C.A.; MacDonald, M.E. Enhanced Akt signaling is an early pro-survival response that reflects N-methyl-D-aspartate receptor activation in Huntington's disease knock-in striatal cells. J. Biol. Chem., 2003, 278(50), 50514-50522
265. Datta, S.R.; Brunet, A.; Greenberg, M.E. Cellular survival: a play in three Akts. Genes Dev., 1999, 13(22), 2905-2927
266. Kandel, E.S.; Hay, N. The regulation and activities of the multifunctional serine/threonine kinase Akt/PKB. Exp. Cell Res., 1999, 253(1), 210-229
267. Humbert, S.; Bryson, E.A.; Cordelieres, F.P.; Connors, N.C.; Datta, S.R.; Finkbeiner, S.; Greenberg, M.E.; Saudou, F. The IGF-1/Akt pathway is neuroprotective in Huntington's disease and involves Huntingtin phosphorylation by Akt. Dev. Cell, 2002, 2(6), 831-837
268. Warby, S.C.; Doty, C.N.; Graham, R.K.; Shively, J.; Singaraja, R.R.; Hayden, M.R. Phosphorylation of huntingtin reduces the accumulation of its nuclear fragments. Mol. Cell Neurosci., 2009, 40(2), 121-127
269. Benn, C.L.; Slow, E.J.; Farrell, L.A.; Graham, R.; Deng, Y.; Hayden, M.R.; Cha, J.H. Glutamate receptor abnormalities in the YAC128 transgenic mouse model of Huntington's disease. Neuroscience, 2007, 147(2), 354-372
270. Alzheimer, A.; Stelzmann, R.A.; Schnitzlein, H.N.; Murtagh, F.R. An English translation of Alzheimer's 1907 paper, Uber eine eigenartige Erkankung der Hirnrinde. Clin. Anat., 1995, 8(6), 429-431
271. Waldemar, G.; Dubois, B.; Emre, M.; Georges, J.; McKeith, I.G.; Rossor, M.; Scheltens, P.; Tariska, P.; Winblad, B. Recommendations for the diagnosis and management of Alzheimer's disease and other disorders associated with dementia: EFNS guideline. Eur. J. Neurol., 2007, 14(1), e1-26
272. Kosik, K.S.; Joachim, C.L.; Selkoe, D.J. Microtubule-associated protein tau (tau) is a major antigenic component of paired helical filaments in Alzheimer disease. Proc. Natl. Acad. Sci. USA, 1986, 83(11), 4044-4048
273. Wood, J.G.; Mirra, S.S.; Pollock, N.J.; Binder, L.I. Neurofibrillary tangles of Alzheimer disease share antigenic determinants with the axonal microtubule-associated protein tau (tau). Proc. Natl. Acad. Sci. USA, 1986, 83(11), 4040-4043
274. Glenner, G.G.; Wong, C.W. Alzheimer's disease: initial report of the purification and characterization of a novel cerebrovascular amyloid protein. Biochem. Biophys. Res. Commun., 1984, 120(3), 885-890
275. Kang, J.; Lemaire, H.G.; Unterbeck, A.; Salbaum, J.M.; Masters, C.L.; Grzeschik, K.H.; Multhaup, G.; Beyreuther, K.; Muller-Hill, B. The precursor of Alzheimer's disease amyloid A4 protein resembles a cell-surface receptor. Nature, 1987, 325(6106), 733-736
276. Esch, F.S.; Keim, P.S.; Beattie, E.C.; Blacher, R.W.; Culwell, A.R.; Oltersdorf, T.; McClure, D.; Ward, P.J. Cleavage of amyloid beta peptide during constitutive processing of its precursor. Science, 1990, 248(4959), 1122-1124
277. Chow, V.W.; Mattson, M.P.; Wong, P.C.; Gleichmann, M. An Overview of APP processing enzymes and products. Neuromol. Med., 2009, in press
278. Terry, R.D.; Masliah, E.; Salmon, D.P.; Butters, N.; DeTeresa, R.; Hill, R.; Hansen, L.A.; Katzman, R. Physical basis of cognitive alterations in Alzheimer's disease: synapse loss is the major correlate of cognitive impairment. Ann. Neurol., 1991, 30(4), 572-580
279. Terry, R.D. Alzheimer's disease and the aging brain. J. Geriatr. Psychiatry Neurol., 2006, 19(3), 125-128
280. Selkoe, D.J. Alzheimer's disease is a synaptic failure. Science, 2002, 298(5594), 789-791
281. Pizzi, M.; Sarnico, I.; Boroni, F.; Benarese, M.; Steimberg, N.; Mazzoleni, G.; Dietz, G.P.; Bahr, M.; Liou, H.C.; Spano, P.F. NF-kappaB factor c-Rel mediates neuroprotection elicited by mGlu5 receptor agonists against amyloid beta-peptide toxicity. Cell Death Differ., 2005, 12(7), 761-772
282. Westmark, C.J.; Malter, J.S. FMRP mediates mGluR5-dependent translation of amyloid precursor protein. PLoS. Biol., 2007, 5(3), e52
283. Stephenson, D.T.; Clemens, J.A. Metabotropic glutamate receptor activation in vivo induces intraneuronal amyloid immunoreactivity in guinea pig hippocampus. Neurochem. Int., 1998, 33(1), 83-93
284. Lee, R.K.; Wurtman, R.J.; Cox, A.J.; Nitsch, R.M. Amyloid precursor protein processing is stimulated by metabotropic glutamate receptors. Proc. Natl. Acad. Sci. USA, 1995, 92(17), 8083-8087
285. Lee, R.K.; Jimenez, J.; Cox, A.J.; Wurtman, R.J. Metabotropic glutamate receptors regulate APP processing in hippocampal neurons and cortical astrocytes derived from fetal rats. Ann. NY Acad. Sci., 1996, 777, 338-343
286. Ulus, I.H.; Wurtman, R.J. Metabotropic glutamate receptor agonists increase release of soluble amyloid precursor protein derivatives from rat brain cortical and hippocampal slices. J. Pharmacol. Exp. Ther., 1997, 281(1), 149-154
287. Casley, C.S.; Lakics, V.; Lee, H.G.; Broad, L.M.; Day, T.A.; Cluett, T.; Smith, M.A.; O'Neill, M.J.; Kingston, A.E. Up-regulation of astrocyte metabotropic glutamate receptor 5 by amyloid-beta peptide. Brain Res. 2009 Epub ahead of print]
288. Roselli, F.; Hutzler, P.; Wegerich, Y.; Livrea, P.; Almeida, O.F. Disassembly of shank and homer synaptic clusters is driven by soluble beta-amyloid(1-40) through divergent NMDAR-dependent signalling pathways. PLoS. One, 2009, 4(6), e6011
289. Albasanz, J.L.; Dalfo, E.; Ferrer, I.; Martin, M. Impaired metabotropic glutamate receptor/phospholipase C signaling pathway in the cerebral cortex in Alzheimer's disease and dementia with Lewy bodies correlates with stage of Alzheimer's-disease-related changes. Neurobiol. Dis., 2005, 20(3), 685-693
290. Li, S.; Hong, S.; Shepardson, N.E.; Walsh, D.M.; Shankar, G.M.; Selkoe, D. Soluble oligomers of amyloid Beta protein facilitate hippocampal long-term depression by disrupting neuronal glutamate uptake. Neuron, 2009, 62(6), 788-801
291. Ye, L.; Qiao, J.T. Suppressive action produced by beta-amyloid peptide fragment 31-35 on long-term potentiation in rat hippocampus is N-methyl-D-aspartate receptor-independent: it's offset by (-)huperzine A. Neurosci. Lett., 1999, 275(3), 187-190
292. Chen, Q.S.; Kagan, B.L.; Hirakura, Y.; Xie, C.W. Impairment of hippocampal long-term potentiation by Alzheimer amyloid beta-peptides. J. Neurosci. Res., 2000, 60(1), 65-72
293. Zhang, J.M.; Wu, M.N.; Qi, J.S.; Qiao, J.T. Amyloid beta-protein fragment 31-35 suppresses long-term potentiation in hippocampal CA1 region of rats in vivo. Synapse, 2006, 60(4), 307-313
294. Zhang, J.F.; Qi, J.S.; Qiao, J.T. Protein kinase C mediates amyloid beta-protein fragment 31-35-induced suppression of hippocampal late-phase long-term potentiation in vivo. Neurobiol. Learn. Mem., 2009, 91(3), 226-234
295. Wang, Q.; Walsh, D.M.; Rowan, M.J.; Selkoe, D.J.; Anwyl, R. Block of long-term potentiation by naturally secreted and synthetic amyloid beta-peptide in hippocampal slices is mediated via activation of the kinases c-Jun N-terminal kinase, cyclin-dependent kinase 5, and p38 mitogen-activated protein kinase as well as metabotropic glutamate receptor type 5. J. Neurosci., 2004, 24(13), 3370-3378
296. Shankar, G.M.; Li, S.; Mehta, T.H.; Garcia-Munoz, A.; Shepardson, N.E.; Smith, I.; Brett, F.M.; Farrell, M.A.; Rowan, M.J.; Lemere, C.A.; Regan, C.M.; Walsh, D.M.; Sabatini, B.L.; Selkoe, D.J. Amyloid-beta protein dimers isolated directly from Alzheimer's brains impair synaptic plasticity and memory. Nat. Med., 2008, 14(8), 837-842
297. Cheng, L.; Yin, W.J.; Zhang, J.F.; Qi, J.S. Amyloid beta-protein fragments 25-35 and 31-35 potentiate long-term depression in hippocampal CA1 region of rats in vivo. Synapse, 2009, 63(3), 206-214
298. Tyszkiewicz, J.P.; Yan, Z. Beta-Amyloid peptides impair PKC-dependent functions of metabotropic glutamate receptors in prefrontal cortical neurons. J. Neurophysiol., 2005, 93(6), 3102-3111
299. Kumar, A.; Calne, S.M.; Schulzer, M.; Mak, E.; Wszolek, Z.; Van, N.C.; Tsui, J.K.; Stoessl, A.J.; Calne, D.B. Clustering of Parkinson disease: shared cause or coincidence? Arch. Neurol., 2004, 61(7), 1057-1060
300. Seidler, A.; Hellenbrand, W.; Robra, B.P.; Vieregge, P.; Nischan, P.; Joerg, J.; Oertel, W.H.; Ulm, G.; Schneider, E. Possible environmental, occupational, and other etiologic factors for Parkinson's disease: a case-control study in Germany. Neurology, 1996, 46(5), 1275-1284
301. Pisani, A.; Bonsi, P.; Centonze, D.; Gubellini, P.; Bernardi, G.; Calabresi, P. Targeting striatal cholinergic interneurons in Parkinson's disease: focus on metabotropic glutamate receptors. Neuropharmacology, 2003, 45(1), 45-56
302. Campusano, J.M.; Abarca, J.; Forray, M.I.; Gysling, K.; Bustos, G. Modulation of dendritic release of dopamine by metabotropic glutamate receptors in rat substantia nigra. Biochem. Pharmacol., 2002, 63(7), 1343-1352
303. Shimazoe, T.; Doi, Y.; Arai, I.; Yoshimatsu, A.; Fukumoto, T.; Watanabe, S. Both metabotropic glutamate I and II receptors mediate augmentation of dopamine release from the striatum in methamphetamine-sensitized rats. Jpn. J. Pharmacol., 2002, 89(1), 85-88
304. Sanchez-Pernaute, R.; Wang, J.Q.; Kuruppu, D.; Cao, L.; Tueckmantel, W.; Kozikowski, A.; Isacson, O.; Brownell, A.L. Enhanced binding of metabotropic glutamate receptor type 5 (mGluR5) PET tracers in the brain of parkinsonian primates. Neuroimage, 2008, 42(1), 248-251
305. Samadi, P.; Gregoire, L.; Morissette, M.; Calon, F.; Hadj, T.A.; Dridi, M.; Belanger, N.; Meltzer, L.T.; Bedard, P.J.; Di, P.T. mGluR5 metabotropic glutamate receptors and dyskinesias in MPTP monkeys. Neurobiol. Aging, 2008, 29(7), 1040-1051
306. Kaneda, K.; Tachibana, Y.; Imanishi, M.; Kita, H.; Shigemoto, R.; Nambu, A.; Takada, M. Down-regulation of metabotropic glutamate receptor 1alpha in globus pallidus and substantia nigra of parkinsonian monkeys. Eur. J. Neurosci., 2005, 22(12), 3241-3254
307. Turle-Lorenzo, N.; Breysse, N.; Baunez, C.; Amalric, M. Functional interaction between mGlu 5 and NMDA receptors in a rat model of Parkinson's disease. Psychopharmacology (Berl.), 2005, 179(1), 117-127
308. Chen, L.; Zhang, Q.J.; Liu, J.; Wang, S.; Ali, U.; Gui, Z.H.; Wang, Y. Chronic, systemic treatment with a metabotropic glutamate receptor 5 antagonist in 6-hydroxydopamine partially lesioned rats reverses abnormal firing of dopaminergic neurons. Brain Res., 2009, 1286, 192-200
309. De, L.E.; Manago, F.; Giordani, F.; Petrosino, F.; Lopez, S.; Oliverio, A.; Amalric, M.; Mele, A. Metabotropic glutamate receptors 5 blockade reverses spatial memory deficits in a mouse model of Parkinson's disease. Neuropsychopharmacology, 2009, 34(3), 729-738
310. Aguirre, J.A.; Andbjer, B.; Gonzalez-Baron, S.; Hansson, A.; Stromberg, I.; Agnati, L.F.; Fuxe, K. Group I mGluR antagonist AIDA protects nigral DA cells from MPTP-induced injury. Neuroreport, 2001, 12(12), 2615-2617
311. Vernon, A.C.; Zbarsky, V.; Datla, K.P.; Croucher, M.J.; Dexter, D.T. Subtype selective antagonism of substantia nigra pars compacta Group I metabotropic glutamate receptors protects the nigrostriatal system against 6-hydroxydopamine toxicity in vivo. J. Neurochem., 2007, 103(3), 1075-1091
312. Battaglia, G.; Busceti, C.L.; Molinaro, G.; Biagioni, F.; Storto, M.; Fornai, F.; Nicoletti, F.; Bruno, V. Endogenous activation of mGlu5 metabotropic glutamate receptors contributes to the development of nigro-striatal damage induced by 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine in mice. J. Neurosci., 2004, 24(4), 828-835
313. Golembiowska, K.; Konieczny, J.; Ossowska, K.; Wolfarth, S. The role of striatal metabotropic glutamate receptors in degeneration of dopamine neurons: review article. Amino Acids, 2002, 23(1-3), 199-205
314. Dalfo, E.; Albasanz, J.L.; Martin, M.; Ferrer, I. Abnormal metabotropic glutamate receptor expression and signaling in the cerebral cortex in diffuse Lewy body disease is associated with irregular alpha-synuclein/phospholipase C (PLCbeta1) interactions. Brain Pathol., 2004, 14(4), 388-398
315. Pronin, A.N.; Morris, A.J.; Surguchov, A.; Benovic, J.L. Synucleins are a novel class of substrates for G protein-coupled receptor kinases. J. Biol. Chem., 2000, 275(34), 26515-26522
316. Koob, G.F.; Sanna, P.P.; Bloom, F.E. Neuroscience of addiction. Neuron, 1998, 21(3), 467-476
317. Koob, G.F.; Ahmed, S.H.; Boutrel, B.; Chen, S.A.; Kenny, P.J.; Markou, A.; O'Dell, L.E.; Parsons, L.H.; Sanna, P.P. Neurobiological mechanisms in the transition from drug use to drug dependence. Neurosci. Biobehav. Rev., 2004, 27(8), 739-749
318. Kenny, P.J.; Markou, A. The ups and downs of addiction: role of metabotropic glutamate receptors. Trends Pharmacol. Sci., 2004, 25(5), 265-272
319. Olive, M.F. Metabotropic glutamate receptor ligands as potential therapeutics for addiction. Curr. Drug Abuse Rev., 2009, 2(1), 883-989
320. Chiamulera, C.; Epping-Jordan, M.P.; Zocchi, A.; Marcon, C.; Cottiny, C.; Tacconi, S.; Corsi, M.; Orzi, F.; Conquet, F. Reinforcing and locomotor stimulant effects of cocaine are absent in mGluR5 null mutant mice. Nat. Neurosci., 2001, 4(9), 873-874
321. Kenny, P.J.; Boutrel, B.; Gasparini, F.; Koob, G.F.; Markou, A. Metabotropic glutamate 5 receptor blockade may attenuate cocaine self-administration by decreasing brain reward function in rats. Psychopharmacology (Berl.), 2005, 179(1), 247-254
322. Lee, B.; Platt, D.M.; Rowlett, J.K.; Adewale, A.S.; Spealman, R.D. Attenuation of behavioral effects of cocaine by the Metabotropic Glutamate Receptor 5 Antagonist 2-Methyl-6-(phenylethynyl)-pyridine in squirrel monkeys: comparison with dizocilpine. J. Pharmacol. Exp. Ther., 2005, 312(3), 1232-1240
323. Markou, A. Metabotropic glutamate receptor antagonists: novel therapeutics for nicotine dependence and depression? Biol. Psychiatry, 2007, 61(1), 17-22
324. Paterson, N.E.; Semenova, S.; Gasparini, F.; Markou, A. The mGluR5 antagonist MPEP decreased nicotine self-administration in rats and mice. Psychopharmacology (Berl.) 2003, 167(3), 257-264
325. Bespalov, A.Y.; Dravolina, O.A.; Sukhanov, I.; Zakharova, E.; Blokhina, E.; Zvartau, E.; Danysz, W.; van, H.G.; Markou, A. Metabotropic glutamate receptor (mGluR5) antagonist MPEP attenuated cue-and schedule-induced reinstatement of nicotine self-administration behavior in rats. Neuropharmacology, 2005, 49(Suppl 1), 167-178
326. Backstrom, P.; Bachteler, D.; Koch, S.; Hyytia, P.; Spanagel, R. mGluR5 antagonist MPEP reduces ethanol-seeking and relapse behavior. Neuropsychopharmacology, 2004, 29(5), 921-928
327. Hodge, C.W.; Miles, M.F.; Sharko, A.C.; Stevenson, R.A.; Hillmann, J.R.; Lepoutre, V.; Besheer, J.; Schroeder, J.P. The mGluR5 antagonist MPEP selectively inhibits the onset and maintenance of ethanol self-administration in C57BL/6J mice. Psychopharmacology (Berl.), 2006, 183(4), 429-438
328. Gass, J.T.; Osborne, M.P.; Watson, N.L.; Brown, J.L.; Olive, M.F. mGluR5 antagonism attenuates methamphetamine reinforcement and prevents reinstatement of methamphetamine-seeking behavior in rats. Neuropsychopharmacology, 2009, 34(4), 820-833
329. McGeehan, A.J.; Olive, M.F. The mGluR5 antagonist MPEP reduces the conditioned rewarding effects of cocaine but not other drugs of abuse. Synapse, 2003, 47(3), 240-242
330. Popik, P.; Wrobel, M. Morphine conditioned reward is inhibited by MPEP, the mGluR5 antagonist. Neuropharmacology, 2002, 43(8), 1210-1217
331. Gabra, B.H.; Smith, F.L.; Navarro, H.A.; Carroll, F.I.; Dewey, W.L. mGluR5 antagonists that block calcium mobilization in vitro also reverse (S)-3,5-DHPG-induced hyperalgesia and morphine antinociceptive tolerance in vivo. Brain Res., 2008, 1187, 58-66
332. Palucha, A.; Branski, P.; Pilc, A. Selective mGlu5 receptor antagonist MTEP attenuates naloxone-induced morphine with-drawal symptoms. Pol. J. Pharmacol., 2004, 56(6), 863-866
333. Dravolina, O.A.; Zakharova, E.S.; Shekunova, E.V.; Zvartau, E.E.; Danysz, W.; Bespalov, A.Y. mGlu1 receptor blockade attenuates cue-and nicotine-induced reinstatement of extinguished nicotine self-administration behavior in rats. Neuropharmacology, 2007, 52(2), 263-269
334. Kotlinska, J.; Bochenski, M. Comparison of the effects of mGluR1 and mGluR5 antagonists on the expression of behavioral sensitization to the locomotor effect of morphine and the morphine withdrawal jumping in mice. Eur. J. Pharmacol., 2007, 558(1-3), 113-118
335. Xie, X.; Ramirez, D.R.; Lasseter, H.C.; Fuchs, R.A. Effects of mGluR1 antagonism in the dorsal hippocampus on drug context-induced reinstatement of cocaine-seeking behavior in rats. Psychopharmacology (Berl.), 2009, 208(1), 1-11
336. Yu, M.F.; Lin, T.Y.; Ho, W.H.; Yin, H.S. Amphetamine induces differential changes in the gene expression of metabotropic glutamate receptor 5 in cultured cortical and hippocampal neurons. J. Mol. Neurosci., 2001, 17(1), 13-24
337. Yu, M.F.; Lin, W.W.; Li, L.T.; Yin, H.S. Activation of metabotropic glutamate receptor 5 is associated with effect of amphetamine on brain neurons. Synapse, 2003, 50(4), 334-344
338. Freeman, W.M.; Brebner, K.; Lynch, W.J.; Robertson, D.J.; Roberts, D.C.; Vrana, K.E. Cocaine-responsive gene expression changes in rat hippocampus. Neuroscience, 2001, 108(3), 371-380
339. Swanson, C.J.; Baker, D.A.; Carson, D.; Worley, P.F.; Kalivas, P.W. Repeated cocaine administration attenuates group I metabotropic glutamate receptor-mediated glutamate release and behavioral activation: a potential role for Homer. J. Neurosci., 2001, 21(22), 9043-9052
340. Szumlinski, K.K.; Dehoff, M.H.; Kang, S.H.; Frys, K.A.; Lominac, K.D.; Klugmann, M.; Rohrer, J.; Griffin, W. III; Toda, S.; Champtiaux, N.P.; Berry, T.; Tu, J.C.; Shealy, S.E.; During, M.J.; Middaugh, L.D.; Worley, P.F.; Kalivas, P.W. Homer proteins regulate sensitivity to cocaine. Neuron, 2004, 43(3), 401-413
341. Zhang, L.; Lou, D.; Jiao, H.; Zhang, D.; Wang, X.; Xia, Y.; Zhang, J.; Xu, M. Cocaine-induced intracellular signaling and gene expression are oppositely regulated by the dopamine D1 and D3 receptors. J. Neurosci., 2004, 24(13), 3344-3354
342. Berhow, M.T.; Hiroi, N.; Nestler, E.J. Regulation of ERK (extracellular signal regulated kinase), part of the neurotrophin signal transduction cascade, in the rat mesolimbic dopamine system by chronic exposure to morphine or cocaine. J. Neurosci., 1996, 16(15), 4707-4715
343. Valjent, E.; Pascoli, V.; Svenningsson, P.; Paul, S.; Enslen, H.; Corvol, J.C.; Stipanovich, A.; Caboche, J.; Lombroso, P.J.; Nairn, A.C.; Greengard, P.; Herve, D.; Girault, J.A. Regulation of a protein phosphatase cascade allows convergent dopamine and glutamate signals to activate ERK in the striatum. Proc. Natl. Acad. Sci. USA, 2005, 102(2), 491-496
344. Shi, X.; McGinty, J.F. Extracellular signal-regulated mitogen-activated protein kinase inhibitors decrease amphetamine-induced behavior and neuropeptide gene expression in the striatum. Neuroscience, 2006, 138(4), 1289-1298
345. Li, L.Y.; Chang, K.J. The stimulatory effect of opioids on mitogen-activated protein kinase in Chinese hamster ovary cells transfected to express mu-opioid receptors. Mol. Pharmacol., 1996, 50(3), 599-602
346. Valjent, E.; Corvol, J.C.; Pages, C.; Besson, M.J.; Maldonado, R.; Caboche, J. Involvement of the extracellular signal-regulated kinase cascade for cocaine-rewarding properties. J. Neurosci., 2000, 20(23), 8701-8709
347. Jenab, S.; Festa, E.D.; Nazarian, A.; Wu, H.B.; Sun, W.L.; Hazim, R.; Russo, S.J.; Quinones-Jenab, V. Cocaine induction of ERK proteins in dorsal striatum of Fischer rats. Brain Res. Mol. Brain Res. 2005, 142(2), 134-138
348. Lu, L.; Hope, B.T.; Dempsey, J.; Liu, S.Y.; Bossert, J.M.; Shaham, Y. Central amygdala ERK signaling pathway is critical to incubation of cocaine craving. Nat. Neurosci., 2005, 8(2), 212-219
349. Choe, E.S.; Chung, K.T.; Mao, L.; Wang, J.Q. Amphetamine increases phosphorylation of extracellular signal-regulated kinase and transcription factors in the rat striatum via group I metabotropic glutamate receptors. Neuropsychopharmacology, 2002, 27(4), 565-575
350. Schroeder, J.P.; Spanos, M.; Stevenson, J.R.; Besheer, J.; Salling, M.; Hodge, C.W. Cue-induced reinstatement of alcohol-seeking behavior is associated with increased ERK1/2 phosphorylation in specific limbic brain regions: blockade by the mGluR5 antagonist MPEP. Neuropharmacology, 2008, 55(4), 546-554
351. Grueter, B.A.; Gosnell, H.B.; Olsen, C.M.; Schramm-Sapyta, N.L.; Nekrasova, T.; Landreth, G.E.; Winder, D.G. Extracellular-signal regulated kinase 1-dependent metabotropic glutamate receptor 5-induced long-term depression in the bed nucleus of the stria terminalis is disrupted by cocaine administration. J. Neurosci., 2006, 26(12), 3210-3219
352. Tonini, R.; Ciardo, S.; Cerovic, M.; Rubino, T.; Parolaro, D.; Mazzanti, M.; Zippel, R. ERK-dependent modulation of cerebellar synaptic plasticity after chronic Delta9-tetrahydrocannabinol exposure. J. Neurosci., 2006, 26(21), 5810-5818
353. Mao, J.; Price, D.D.; Phillips, L.L.; Lu, J.; Mayer, D.J. Increases in protein kinase C gamma immunoreactivity in the spinal cord of rats associated with tolerance to the analgesic effects of morphine. Brain Res., 1995, 677(2), 257-267
354. Newton, P.M.; Ron, D. Protein kinase C and alcohol addiction. Pharmacol. Res., 2007, 55(6), 570-577
355. Mayer, D.J.; Mao, J.; Price, D.D. The development of morphine tolerance and dependence is associated with translocation of protein kinase C. Pain, 1995, 61(3), 365-374
356. Dale, L.B.; Babwah, A.V.; Bhattacharya, M.; Kelvin, D.J.; Ferguson, S.S. Spatial-temporal patterning of metabotropic glutamate receptor-mediated inositol 1,4,5-triphosphate, calcium, and protein kinase C oscillations: protein kinase C-dependent receptor phosphorylation is not required. J. Biol. Chem., 2001, 276(38), 35900-35908
357. Codazzi, F.; Teruel, M.N.; Meyer, T. Control of astrocyte Ca(2+) oscillations and waves by oscillating translocation and activation of protein kinase C. Curr. Biol., 2001, 11(14), 1089-1097
358. Annoura, H.; Fukunaga, A.; Uesugi, M.; Tatsuoka, T.; Horikawa, Y. A novel class of antagonist for metabotropic glutamate receptors, 7-(hydroxyimino)cyclopropachromen-1a-carboxylates. Bioorg. Med. Chem. Lett., 1996, 6[7], 763-766
359. Lavreysen, H.; Janssen, C.; Bischoff, F.; Langlois, X.; Leysen, J.E.; Lesage, A.S. [3H]R214127: a novel high-affinity radioligand for the mGlu1 receptor reveals a common binding site shared by multiple allosteric antagonists. Mol.Pharmacol., 2003, 63(5), 1082-1093
360. Malherbe, P.; Kratochwil, N.; Knoflach, F.; Zenner, M.T.; Kew, J.N.; Kratzeisen, C.; Maerki, H.P.; Adam, G.; Mutel, V. Mutational analysis and molecular modeling of the allosteric binding site of a novel, selective, noncompetitive antagonist of the metabotropic glutamate 1 receptor. J. Biol. Chem., 2003, 278(10), 8340-8347
361. Varney, M.A.; Cosford, N.D.; Jachec, C.; Rao, S.P.; Sacaan, A.; Lin, F.F.; Bleicher, L.; Santori, E.M.; Flor, P.J.; Allgeier, H.; Gasparini, F.; Kuhn, R.; Hess, S.D.; Velicelebi, G.; Johnson, E.C. SIB-1757 and SIB-1893: selective, noncompetitive antagonists of metabotropic glutamate receptor type 5. J. Pharmacol. Exp. Ther., 1999, 290(1), 170-181
362. Ishikawa, K.; Nash, S.R.; Nishimune, A.; Neki, A.; Kaneko, S.; Nakanishi, S. Competitive interaction of seven in absentia homolog-1A and Ca2+/calmodulin with the cytoplasmic tail of group 1 metabotropic glutamate receptors. Genes Cells, 1999, 4(7), 381-390
363. Ciruela, F.; Robbins, M.J.; Willis, A.C.; McIlhinney, R.A. Interactions of the C terminus of metabotropic glutamate receptor type 1alpha with rat brain proteins: evidence for a direct interaction with tubulin. J. Neurochem., 1999, 72(1), 346-354.